BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Busuttil RW, Tanaka K. The utility of marginal donors in liver transplantation. Liver Transpl. 2003;9:651-663. [PMID: 12827549 DOI: 10.1053/jlts.2003.50105] [Cited by in Crossref: 494] [Cited by in F6Publishing: 424] [Article Influence: 26.0] [Reference Citation Analysis]
Number Citing Articles
1 McCormack L, Dutkowski P, El-Badry AM, Clavien PA. Liver transplantation using fatty livers: always feasible? J Hepatol. 2011;54:1055-1062. [PMID: 21145846 DOI: 10.1016/j.jhep.2010.11.004] [Cited by in Crossref: 168] [Cited by in F6Publishing: 156] [Article Influence: 14.0] [Reference Citation Analysis]
2 Akateh C, Beal EW, Kim JL, Reader BF, Maynard K, Zweier JL, Whitson BA, Black SM. Intrahepatic Delivery of Pegylated Catalase Is Protective in a Rat Ischemia/Reperfusion Injury Model. J Surg Res 2019;238:152-63. [PMID: 30771685 DOI: 10.1016/j.jss.2019.01.028] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
3 Silberhumer GR, Rahmel A, Karam V, Gonen M, Gyoeri G, Kern B, Adam R, Muehlbacher F, Rogiers X, Burroughs AK, Berlakovich GA. The difficulty in defining extended donor criteria for liver grafts: the Eurotransplant experience. Transpl Int. 2013;26:990-998. [PMID: 23931659 DOI: 10.1111/tri.12156] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 3.6] [Reference Citation Analysis]
4 Lake JR, Shorr JS, Steffen BJ, Chu AH, Gordon RD, Wiesner RH. Differential effects of donor age in liver transplant recipients infected with hepatitis B, hepatitis C and without viral hepatitis. Am J Transplant. 2005;5:549-557. [PMID: 15707410 DOI: 10.1111/j.1600-6143.2005.00741.x] [Cited by in Crossref: 138] [Cited by in F6Publishing: 119] [Article Influence: 8.1] [Reference Citation Analysis]
5 Ishizaki M, Kaibori M, Uchida Y, Hijikawa T, Tanaka H, Ozaki T, Tokuhara K, Matsui K, Kwon A, Kamiyama Y, Nishizawa M, Okumura T. PROTECTIVE EFFECT OF FR183998, A Na+/H+ EXCHANGER INHIBITOR, AND ITS INHIBITION OF iNOS INDUCTION IN HEPATIC ISCHEMIA-REPERFUSION INJURY IN RATS. Shock 2008;30:311-7. [DOI: 10.1097/shk.0b013e318164ef14] [Cited by in Crossref: 20] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
6 Hiatt JR, Carmody IC, Busuttil RW. Should we expand the criteria for hepatocellular carcinoma with living-donor liver transplantation?--no, never. J Hepatol 2005;43:573-7. [PMID: 16112768 DOI: 10.1016/j.jhep.2005.07.017] [Cited by in Crossref: 37] [Cited by in F6Publishing: 30] [Article Influence: 2.2] [Reference Citation Analysis]
7 Fondevila C, Jiménez-Galanes S, García-Valdecasas JC. [How can the number of liver transplantations be increased?]. Gastroenterol Hepatol 2009;32:519-30. [PMID: 19608299 DOI: 10.1016/j.gastrohep.2009.01.184] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
8 Haberal M, Dalgic A. New concepts in organ transplantation. Transplantation Proceedings 2004;36:1219-24. [DOI: 10.1016/j.transproceed.2004.05.035] [Cited by in Crossref: 33] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]
9 Croce AC, Ferrigno A, Bertone V, Piccolini VM, Berardo C, Di Pasqua LG, Rizzo V, Bottiroli G, Vairetti M. Fatty liver oxidative events monitored by autofluorescence optical diagnosis: Comparison between subnormothermic machine perfusion and conventional cold storage preservation. Hepatol Res 2017;47:668-82. [PMID: 27448628 DOI: 10.1111/hepr.12779] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
10 Jochmans I, Fieuws S, Monbaliu D, Pirenne J. “Model for Early Allograft Function” Outperforms “Early Allograft Dysfunction” as a Predictor of Transplant Survival. Transplantation 2017;101:e258-64. [DOI: 10.1097/tp.0000000000001833] [Cited by in Crossref: 29] [Cited by in F6Publishing: 4] [Article Influence: 5.8] [Reference Citation Analysis]
11 Amano H, Tashiro H, Itamoto T, Oshita A, Niitsu H, Ohdan H, Asahara T. Successful Living Donor Left Liver Transplantation by Using Liver Graft With Multiple Large Cysts: A Case Report. Transplantation Proceedings 2009;41:3923-6. [DOI: 10.1016/j.transproceed.2009.02.099] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
12 Kim JE, Jeon JP, No HC, Choi JH, Lee SH, Ryu KH, Kim ES. The effects of magnesium pretreatment on reperfusion injury during living donor liver transplantation. Korean J Anesthesiol 2011;60:408-15. [PMID: 21738843 DOI: 10.4097/kjae.2011.60.6.408] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
13 Burra P, Porte RJ. Should donors and recipients be matched in liver transplantation? J Hepatol. 2006;45:488-494. [PMID: 16919837 DOI: 10.1016/j.jhep.2006.07.021] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
14 Attia M, Silva MA, Mirza DF. The marginal liver donor--an update. Transpl Int. 2008;21:713-724. [PMID: 18492121 DOI: 10.1111/j.1432-2277.2008.00696.x] [Cited by in Crossref: 78] [Cited by in F6Publishing: 71] [Article Influence: 5.6] [Reference Citation Analysis]
15 Orci LA, Lacotte S, Oldani G, Morel P, Mentha G, Toso C. The Role of Hepatic Ischemia–Reperfusion Injury and Liver Parenchymal Quality on Cancer Recurrence. Dig Dis Sci 2014;59:2058-68. [DOI: 10.1007/s10620-014-3182-7] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
16 de Oliveira THC, Souza DG, Teixeira MM, Amaral FA. Tissue Dependent Role of PTX3 During Ischemia-Reperfusion Injury. Front Immunol 2019;10:1461. [PMID: 31354697 DOI: 10.3389/fimmu.2019.01461] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
17 Maluf DG, Edwards EB, Stravitz RT, Kauffman HM. Impact of the donor risk index on the outcome of hepatitis C virus-positive liver transplant recipients. Liver Transpl. 2009;15:592-599. [PMID: 19479802 DOI: 10.1002/lt.21699] [Cited by in Crossref: 43] [Cited by in F6Publishing: 34] [Article Influence: 3.3] [Reference Citation Analysis]
18 Torres OJ, Pantoja PB, Barbosa ES, Barros Cde A, Servin ET, Servin SC. Hemodynamic alterations during orthotopic liver experimental transplantation in pigs. Acta Cir Bras. 2008;23:135-139. [PMID: 18372958 DOI: 10.1590/S0102-86502008000200005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
19 Chan SC, Fan ST, Lo CM, Liu CL. Effect of side and size of graft on surgical outcomes of adult-to-adult live donor liver transplantation. Liver Transpl. 2007;13:91-98. [PMID: 17192891 DOI: 10.1002/lt.20987] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 2.1] [Reference Citation Analysis]
20 Habka D, Mann D, Landes R, Soto-Gutierrez A. Future Economics of Liver Transplantation: A 20-Year Cost Modeling Forecast and the Prospect of Bioengineering Autologous Liver Grafts. PLoS One 2015;10:e0131764. [PMID: 26177505 DOI: 10.1371/journal.pone.0131764] [Cited by in Crossref: 42] [Cited by in F6Publishing: 37] [Article Influence: 6.0] [Reference Citation Analysis]
21 Wang G, Cheng Y, Liu Y. Comprehensive Evaluation of a Donated After Circulatory Death (DCD) Donor Liver Model in Minipigs. Ann Transplant 2018;23:758-66. [DOI: 10.12659/aot.911072] [Reference Citation Analysis]
22 Liu Z, Zhang X, Xiao Q, Ye S, Lai CH, Luo J, Huang X, Wang W, Zeng C, Zhong Z, Fan X, Xia Z, Xiong Y, Mao X, Ye Q, Wang Y. Pretreatment Donors after Circulatory Death with Simvastatin Alleviates Liver Ischemia Reperfusion Injury through a KLF2-Dependent Mechanism in Rat. Oxid Med Cell Longev 2017;2017:3861914. [PMID: 29348789 DOI: 10.1155/2017/3861914] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
23 Briceño J, Ciria R, de la Mata M, Montero JL, Rufián S, López-cillero P. Extended criteria donors in liver transplant candidates with hepatorenal syndrome: Marginal liver grafts in hepatorenal syndrome. Clinical Transplantation 2011;25:E257-63. [DOI: 10.1111/j.1399-0012.2011.01402.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
24 Tarantola E, Bertone V, Milanesi G, Gruppi C, Ferrigno A, Vairetti M, Barni S, Freitas I. Dipeptidylpeptidase-IV activity and expression reveal decreased damage to the intrahepatic biliary tree in fatty livers submitted to subnormothermic machine-perfusion respect to conventional cold storage. Eur J Histochem 2014;58:2414. [PMID: 25308846 DOI: 10.4081/ejh.2014.2414] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
25 Caso-Maestro O, Jiménez-Romero C, Justo-Alonso I, Calvo-Pulido J, Lora-Pablos D, Marcacuzco-Quinto A, Cambra-Molero F, García-Sesma A, Pérez-Flecha M, Muñoz-Arce C, Loinaz-Segurola C, Manrique-Municio A. Analyzing predictors of graft survival in patients undergoing liver transplantation with donors aged 70 years and over. World J Gastroenterol 2018; 24(47): 5391-5402 [PMID: 30598583 DOI: 10.3748/wjg.v24.i47.5391] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
26 Avolio AW, Nardo B, Agnes S, Montalti R, Pepe G, Cavallari A, Castagneto M. The mismatch choice in liver transplantation: a suggestion for the selection of the recipient in relation to the characteristics of the donor. Transplant Proc. 2005;37:2584-2586. [PMID: 16182751 DOI: 10.1016/j.transproceed.2005.06.054] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
27 Frongillo F, Avolio AW, Nure E, Mulè A, Pepe G, Magalini SC, Agnes S. Quantification of degree of steatosis in extended criteria donor grafts with standardized histologic techniques: implications for graft survival. Transplant Proc 2009;41:1268-72. [PMID: 19460535 DOI: 10.1016/j.transproceed.2009.03.096] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
28 Padrissa-Altés S, Zaouali MA, Boncompagni E, Bonaccorsi-Riani E, Carbonell T, Bardag-Gorce F, Oliva J, French SW, Bartrons R, Roselló-Catafau J. The use of a reversible proteasome inhibitor in a model of Reduced-Size Orthotopic Liver transplantation in rats. Exp Mol Pathol. 2012;93:99-110. [PMID: 22475623 DOI: 10.1016/j.yexmp.2012.03.011] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
29 Vargas PA, Cullen JM, Argo C, Henry Z, Stotts MJ, Intagliata N, Northup P, Oberholzer J, Pelletier S, Goldaracena N. Liver Transplantation With Grafts From Super Obese Donors. Transplant Direct 2021;7:e770. [PMID: 34557587 DOI: 10.1097/TXD.0000000000001225] [Reference Citation Analysis]
30 Nutu A, Justo I, Marcacuzco A, Caso Ó, Manrique A, Calvo J, García-Sesma Á, García-Conde M, Gallego MS, Jiménez-Romero C. Liver transplantation for hepatocellular carcinoma using grafts from uncontrolled circulatory death donation. Sci Rep 2021;11:13520. [PMID: 34188156 DOI: 10.1038/s41598-021-92976-5] [Reference Citation Analysis]
31 Russo L, Gracia-Sancho J, García-Calderó H, Marrone G, García-Pagán JC, García-Cardeña G, Bosch J. Addition of simvastatin to cold storage solution prevents endothelial dysfunction in explanted rat livers. Hepatology 2012;55:921-30. [PMID: 22031447 DOI: 10.1002/hep.24755] [Cited by in Crossref: 65] [Cited by in F6Publishing: 61] [Article Influence: 6.5] [Reference Citation Analysis]
32 Silberhumer GR, Pokorny H, Hetz H, Herkner H, Rasoul-rockenschaub S, Soliman T, Wekerle T, Berlakovich GA, Steininger R, Muehlbacher F. Combination of Extended Donor Criteria and Changes in the Model for End-Stage Liver Disease Score Predict Patient Survival and Primary Dysfunction in Liver Transplantation: A Retrospective Analysis. Transplantation 2007;83:588-92. [DOI: 10.1097/01.tp.0000255319.07499.b7] [Cited by in Crossref: 64] [Cited by in F6Publishing: 46] [Article Influence: 4.3] [Reference Citation Analysis]
33 Oliveira THC, Marques PE, Proost P, Teixeira MMM. Neutrophils: a cornerstone of liver ischemia and reperfusion injury. Lab Invest. 2018;98:51-62. [PMID: 28920945 DOI: 10.1038/labinvest.2017.90] [Cited by in Crossref: 49] [Cited by in F6Publishing: 53] [Article Influence: 9.8] [Reference Citation Analysis]
34 Vishwakarma SK, Lakkireddy C, Bardia A, Paspala SAB, Tripura C, Habeeb MA, Khan AA. Bioengineered functional humanized livers: An emerging supportive modality to bridge the gap of organ transplantation for management of end-stage liver diseases. World J Hepatol 2018; 10(11): 822-836 [PMID: 30533183 DOI: 10.4254/wjh.v10.i11.822] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
35 Zaouali MA, Panisello A, Lopez A, Castro C, Folch E, Carbonell T, Rolo A, Palmeira CM, Garcia-Gil A, Adam R, Roselló-Catafau J. GSK3β and VDAC Involvement in ER Stress and Apoptosis Modulation during Orthotopic Liver Transplantation. Int J Mol Sci 2017;18:E591. [PMID: 28282906 DOI: 10.3390/ijms18030591] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
36 Blok JJ, Braat AE, Adam R, Burroughs AK, Putter H, Kooreman NG, Rahmel AO, Porte RJ, Rogiers X, Ringers J; for the European Liver Intestine Transplant Association and the Eurotransplant Liver Intestine Advisory Committee. Validation of the donor risk index in orthotopic liver transplantation within the Eurotransplant region. Liver Transpl 2012;18:112-9. [DOI: 10.1002/lt.22447] [Cited by in Crossref: 74] [Cited by in F6Publishing: 63] [Article Influence: 6.7] [Reference Citation Analysis]
37 Eyraud D, Ben Ayed S, Tanguy ML, Vézinet C, Siksik JM, Bernard M, Fratéa S, Movschin M, Vaillant JC, Coriat P, Hannoun L. Procalcitonin in liver transplantation: are high levels due to donors or recipients? Crit Care 2008;12:R85. [PMID: 18601732 DOI: 10.1186/cc6942] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
38 Leibovici-Weissman Y, Mor E, Leshno M, Shlomai A. Patients' Age Rather Than Model of End-Stage Liver Disease Score Predicts Survival After Liver Transplantation. Dig Dis Sci 2017;62:801-7. [PMID: 28054162 DOI: 10.1007/s10620-016-4423-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
39 Castillo Tuñón JM, Marín Gómez LM, Suárez Artacho G, Cepeda Franco C, Bernal Bellido C, Álamo Martínez JM, Padillo Ruiz FJ, Gómez Bravo MÁ. Risk Factors for No Valid Liver Graft. Multivariate Study Based on the Variables Included in the Donation Protocol of the National Trasplant Organisation. Cir Esp (Engl Ed) 2020;98:591-7. [PMID: 32507309 DOI: 10.1016/j.ciresp.2020.03.021] [Reference Citation Analysis]
40 Nemes B, Gelley F, Zádori G, Görög D, Fehérvári I, Jakab K, Fazakas J, Mándli T, Gerlei Z, Sárváry E, Doros A, Kóbori L. The role of marginal donors in liver transplantation. The Hungarian experience. Orvosi Hetilap 2009;150:2228-36. [DOI: 10.1556/oh.2009.28743] [Cited by in Crossref: 5] [Article Influence: 0.4] [Reference Citation Analysis]
41 Nadig SN, Bratton CF, Karp SJ. Marginal donors in liver transplantation: expanding the donor pool. J Surg Educ. 2007;64:46-50. [PMID: 17320806 DOI: 10.1016/j.cursur.2006.08.001] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.2] [Reference Citation Analysis]
42 Li Z, Hu Z, Xiang J, Zhou J, Yan S, Wu J, Zhou L, Zheng S. Use of hepatitis B surface antigen-positive grafts in liver transplantation: a matched analysis of the US National database. Liver Transpl. 2014;20:35-45. [PMID: 24142889 DOI: 10.1002/lt.23774] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
43 Washburn WK, Meo NA, Halff GA, Roberts JP, Feng S. Factors influencing liver transplant length of stay at two large-volume transplant centers. Liver Transpl. 2009;15:1570-1578. [PMID: 19877222 DOI: 10.1002/lt.21858] [Cited by in Crossref: 39] [Cited by in F6Publishing: 33] [Article Influence: 3.3] [Reference Citation Analysis]
44 Sotiropoulos GC, Paul A, Molmenti E, Lang H, Frilling A, Napieralski BP, Nadalin S, Treckmann J, Brokalaki EI, Gerling T, Broelsch CE, Malagó M. Liver transplantation for hepatocellular carcinoma in cirrhosis within the Eurotransplant area: an additional option with "livers that nobody wants". Transplantation 2005;80:897-902. [PMID: 16249736 DOI: 10.1097/01.tp.0000173644.63692.dc] [Cited by in Crossref: 32] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
45 Pirenne J, Monbaliu D, Van Gelder F, Van Hees D, Aerts R, Verslype C, Van Steenbergen W, Ferdinande P, Fevery J, Nevens F. Liver transplantation using livers from septuagenarian and octogenarian donors: an underused strategy to reduce mortality on the waiting list. Transplant Proc. 2005;37:1180-1181. [PMID: 15848662 DOI: 10.1016/j.transproceed.2004.12.168] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
46 de Oliveira THC, Marques PE, Poosti F, Ruytinx P, Amaral FA, Brandolini L, Allegretti M, Proost P, Teixeira MM. Intravital Microscopic Evaluation of the Effects of a CXCR2 Antagonist in a Model of Liver Ischemia Reperfusion Injury in Mice. Front Immunol. 2018;8:1917. [PMID: 29379500 DOI: 10.3389/fimmu.2017.01917] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
47 Thorling CA, Jin L, Weiss M, Crawford D, Liu X, Burczynski FJ, Liu D, Wang H, Roberts MS. Assessing Steatotic Liver Function after Ischemia-Reperfusion Injury by In Vivo Multiphoton Imaging of Fluorescein Disposition. Drug Metab Dispos 2014;43:154-62. [DOI: 10.1124/dmd.114.060848] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
48 Sampedro B, Cabezas J, Fábrega E, Casafont F, Pons-Romero F. Liver transplantation with donors older than 75 years. Transplant Proc. 2011;43:679-682. [PMID: 21486572 DOI: 10.1016/j.transproceed.2011.01.084] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
49 Benkö T, Belker J, Gallinat A, Treckmann JW, Paul A, Minor T, Hoyer DP. Analysis of Data from the Oxygen Persufflation in Liver Transplantation (OPAL) Study to Determine the Role of Factors Affecting the Hepatic Microcirculation and Early Allograft Dysfunction. Ann Transplant 2019;24:481-8. [PMID: 31417074 DOI: 10.12659/AOT.915214] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
50 Segev DL, Maley WR, Simpkins CE, Locke JE, Nguyen GC, Montgomery RA, Thuluvath PJ. Minimizing risk associated with elderly liver donors by matching to preferred recipients. Hepatology. 2007;46:1907-1918. [PMID: 17918247 DOI: 10.1002/hep.21888] [Cited by in Crossref: 70] [Cited by in F6Publishing: 59] [Article Influence: 5.0] [Reference Citation Analysis]
51 Bacchella T, Galvão FHF, Almeida JLJD, Figueira ER, Moraes AD, Machado MCC. Marginal grafts increase early mortality in liver transplantation. Sao Paulo Med J 2008;126:161-5. [DOI: 10.1590/s1516-31802008000300005] [Cited by in Crossref: 24] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
52 Avellini C, Baccarani U, Trevisan G, Cesaratto L, Vascotto C, D'Aurizio F, Pandolfi M, Adani GL, Tell G. Redox proteomics and immunohistology to study molecular events during ischemia-reperfusion in human liver. Transplant Proc 2007;39:1755-60. [PMID: 17692604 DOI: 10.1016/j.transproceed.2007.05.082] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.2] [Reference Citation Analysis]
53 Moon DB, Lee SG. Liver transplantation. Gut Liver. 2009;3:145-165. [PMID: 20431740 DOI: 10.5009/gnl.2009.3.3.145] [Cited by in Crossref: 54] [Cited by in F6Publishing: 31] [Article Influence: 4.2] [Reference Citation Analysis]
54 Panisello-Roselló A, Verde E, Lopez A, Flores M, Folch-Puy E, Rolo A, Palmeira C, Hotter G, Carbonell T, Adam R, Roselló-Catafau J. Cytoprotective Mechanisms in Fatty Liver Preservation against Cold Ischemia Injury: A Comparison between IGL-1 and HTK. Int J Mol Sci 2018;19:E348. [PMID: 29364854 DOI: 10.3390/ijms19020348] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
55 Ghonem N, Yoshida J, Stolz DB, Humar A, Starzl TE, Murase N, Venkataramanan R. Treprostinil, a prostacyclin analog, ameliorates ischemia-reperfusion injury in rat orthotopic liver transplantation. Am J Transplant 2011;11:2508-16. [PMID: 21668631 DOI: 10.1111/j.1600-6143.2011.03568.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
56 Stangl R, Szijártó A, Ónody P, Tamás J, Tátrai M, Hegedűs V, Blázovics A, Lotz G, Kiss A, Módis K, Gerő D, Szabó C, Kupcsulik P, Harsányi L. Reduction of Liver Ischemia-Reperfusion Injury Via Glutamine Pretreatment. Journal of Surgical Research 2011;166:95-103. [DOI: 10.1016/j.jss.2009.09.047] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
57 Al-freah MAB, Mcphail MJW, Dionigi E, Foxton MR, Auzinger G, Rela M, Wendon JA, O'grady JG, Heneghan MA, Heaton ND, Bernal W. Improving the Diagnostic Criteria for Primary Liver Graft Nonfunction in Adults Utilizing Standard and Transportable Laboratory Parameters: An Outcome-Based Analysis. Am J Transplant 2017;17:1255-66. [DOI: 10.1111/ajt.14230] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
58 Mclean KA, Camilleri-brennan J, Knight SR, Drake TM, Ots R, Shaw CA, Wigmore SJ, Harrison EM. Decision modeling in donation after circulatory death liver transplantation. Liver Transpl 2017;23:594-603. [DOI: 10.1002/lt.24715] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
59 Mangus RS, Fridell JA, Vianna RM, Kwo PY, Chestovich P, Milgrom ML, Kazimi M, Hollinger EF, Read JT, Tector AJ. No difference in clinical transplant outcomes for local and imported liver allografts. Liver Transpl 2009;15:640-7. [DOI: 10.1002/lt.21726] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 2.1] [Reference Citation Analysis]
60 Pratschke J, Weiss S, Neuhaus P, Pascher A. Review of nonimmunological causes for deteriorated graft function and graft loss after transplantation. Transpl Int. 2008;21:512-522. [PMID: 18266771 DOI: 10.1111/j.1432-2277.2008.00643.x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 2.6] [Reference Citation Analysis]
61 Briceño J, Ciria R. Limits for adult liver donation in Spain. Transplant Proc 2014;46:3079-81. [PMID: 25420827 DOI: 10.1016/j.transproceed.2014.09.172] [Reference Citation Analysis]
62 Feng S. The dilemma of high-risk deceased donor livers: Who should get them? Liver Transpl 2010;16:S60-4. [DOI: 10.1002/lt.22142] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
63 Patel RP, Lang JD, Smith AB, Crawford JH. Redox therapeutics in hepatic ischemia reperfusion injury. World J Hepatol 2014; 6(1): 1-8 [PMID: 24653789 DOI: 10.4254/wjh.v6.i1.1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
64 Burra P, Loreno M, Russo FP, Germani G, Galligioni A, Senzolo M, Cillo U, Zanus G, Fagiuoli S, Rugge M. Donor livers with steatosis are safe to use in hepatitis C virus-positive recipients. Liver Transpl. 2009;15:619-628. [PMID: 19479805 DOI: 10.1002/lt.21761] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 2.5] [Reference Citation Analysis]
65 Salvi M, Molinaro L, Metovic J, Patrono D, Romagnoli R, Papotti M, Molinari F. Fully automated quantitative assessment of hepatic steatosis in liver transplants. Comput Biol Med. 2020;123:103836. [PMID: 32658781 DOI: 10.1016/j.compbiomed.2020.103836] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
66 Briceño J, Ciria R, de la Mata M, Rufián S, López-Cillero P. Prediction of graft dysfunction based on extended criteria donors in the model for end-stage liver disease score era. Transplantation 2010;90:530-9. [PMID: 20581766 DOI: 10.1097/TP.0b013e3181e86b11] [Cited by in Crossref: 61] [Cited by in F6Publishing: 16] [Article Influence: 5.1] [Reference Citation Analysis]
67 Diaz GC, Wagener G, Renz JF. Postoperative care/critical care of the transplant patient. Anesthesiol Clin 2013;31:723-35. [PMID: 24287349 DOI: 10.1016/j.anclin.2013.09.001] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
68 Johnson SR, Pavlakis M, Khwaja K, Karp SJ, Curry M, Curran CC, Monaco AP, Hanto DW. Intensive Care Unit Extubation Does Not Preclude Extrarenal Organ Recovery from Donors after Cardiac Death: . Transplantation 2005;80:1244-50. [DOI: 10.1097/01.tp.0000179643.56257.7f] [Cited by in Crossref: 13] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
69 Bader CS, Jin L, Levy RB. STING and transplantation: can targeting this pathway improve outcomes? Blood 2021;137:1871-8. [PMID: 33619537 DOI: 10.1182/blood.2020008911] [Reference Citation Analysis]
70 Zaman MB, Leonard MO, Ryan EJ, Nolan NP, Hoti E, Maguire D, Mulcahy H, Traynor O, Taylor CT, Hegarty JE, Geoghegan JG, O'Farrelly C. Lower expression of Nrf2 mRNA in older donor livers: a possible contributor to increased ischemia-reperfusion injury? Transplantation 2007;84:1272-8. [PMID: 18049112 DOI: 10.1097/01.tp.0000288229.53064.e2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
71 Liu Z, Wang W, Zhuang L, Liu J, Que S, Zhu D, Dong L, Yu J, Zhou L, Zheng S. Clear mortality gap caused by graft macrosteatosis in Chinese patients after cadaveric liver transplantation. Hepatobiliary Surg Nutr 2020;9:739-58. [PMID: 33299829 DOI: 10.21037/hbsn.2019.12.02] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
72 Rayar M, Levi Sandri GB, Cusumano C, Locher C, Houssel-debry P, Camus C, Lombard N, Desfourneaux V, Lakehal M, Meunier B, Sulpice L, Boudjema K. Benefits of temporary portocaval shunt during orthotopic liver transplantation with vena cava preservation: A propensity score analysis. Liver Transpl 2017;23:174-83. [DOI: 10.1002/lt.24650] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
73 Lozanovski VJ, Khajeh E, Fonouni H, Pfeiffenberger J, von Haken R, Brenner T, Mieth M, Schirmacher P, Michalski CW, Weiss KH, Büchler MW, Mehrabi A. The impact of major extended donor criteria on graft failure and patient mortality after liver transplantation. Langenbecks Arch Surg 2018;403:719-31. [PMID: 30112639 DOI: 10.1007/s00423-018-1704-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
74 Fink MA, Angus PW, Gow PJ, Berry SR, Wang BZ, Muralidharan V, Christophi C, Jones RM. Liver transplant recipient selection: MELD vs. clinical judgment. Liver Transpl 2005;11:621-6. [PMID: 15915491 DOI: 10.1002/lt.20428] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
75 Rana A, Joshi M, Price MB, Ganni S, Bakhtiyar SS, Vierling JM, Galvan NT, Cotton RT, O'Mahony CA, Kanwal F, Goss JA. A learning curve in using orphan liver allografts for transplantation. Clin Transplant 2020;34:e13821. [PMID: 32034946 DOI: 10.1111/ctr.13821] [Reference Citation Analysis]
76 Feng S. Increased donor risk: Who should bear the burden? Liver Transpl 2009;15:570-3. [DOI: 10.1002/lt.21790] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
77 Kato H, Duarte S, Miller MG, Busuttil RW, Coito AJ. Overproduction of Tenascin-C Driven by Lipid Accumulation in the Liver Aggravates Hepatic Ischemia/Reperfusion Injury in Steatotic Mice. Liver Transpl 2019;25:288-301. [PMID: 30358115 DOI: 10.1002/lt.25365] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
78 Mogler C, Flechtenmacher C, Schirmacher P, Bergmann F. [Frozen section diagnostics in visceral surgery. Liver, bile ducts and pancreas]. Pathologe 2012;33:413-23. [PMID: 22892660 DOI: 10.1007/s00292-012-1602-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
79 Uemura T, Ramprasad V, Hollenbeak CS, Bezinover D, Kadry Z. Liver transplantation for hepatitis C from donation after cardiac death donors: an analysis of OPTN/UNOS data. Am J Transplant. 2012;12:984-991. [PMID: 22225523 DOI: 10.1111/j.1600-6143.2011.03899.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 2.4] [Reference Citation Analysis]
80 Eggenhofer E, Rovira J, Sabet-baktach M, Groell A, Scherer MN, Dahlke M, Farkas SA, Loss M, Koehl GE, Lang SA, Melter M, Schlitt HJ, Geissler EK, Kroemer A. Unconventional RORγt + T Cells Drive Hepatic Ischemia Reperfusion Injury. J I 2013;191:480-7. [DOI: 10.4049/jimmunol.1202975] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.3] [Reference Citation Analysis]
81 Peng C, Yuan D, Li B, Wei Y, Yan L, Wen T, Zhao J, Yang J, Wang W, Xu M. Body Mass Index Evaluating Donor Hepatic Steatosis in Living Donor Liver Transplantation. Transplantation Proceedings 2009;41:3556-9. [DOI: 10.1016/j.transproceed.2009.06.235] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
82 Jiménez-Galanes S, Meneu-Diaz MJ, Elola-Olaso AM, Pérez-Saborido B, Yiliam FS, Calvo AG, Usera MA, González MC, González JC, González EM. Liver transplantation using uncontrolled non-heart-beating donors under normothermic extracorporeal membrane oxygenation. Liver Transpl. 2009;15:1110-1118. [PMID: 19718635 DOI: 10.1002/lt.21867] [Cited by in Crossref: 75] [Cited by in F6Publishing: 65] [Article Influence: 5.8] [Reference Citation Analysis]
83 Rodrigue JR, Hanto DW, Curry MP. Patients’ Willingness to Accept Expanded Criteria Donor Liver Transplantation: ECD Liver Transplantation. American Journal of Transplantation 2011;11:1705-11. [DOI: 10.1111/j.1600-6143.2011.03592.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
84 Nure E, Lirosi MC, Frongillo F, Bianco G, Silvestrini N, Fiorillo C, Sganga G, Agnes S. Overextended Criteria Donors: Experience of an Italian Transplantation Center. Transplant Proc. 2015;47:2102-2105. [PMID: 26361653 DOI: 10.1016/j.transproceed.2014.11.077] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
85 Shin M, Kim J, Park J, Kwon C, Kim S, Joh J. Effect of Donor–Recipient Age Gradient on Graft Outcomes in Deceased Donor Liver Transplantation. Transplantation Proceedings 2013;45:3013-8. [DOI: 10.1016/j.transproceed.2013.08.019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
86 Frühauf NR, Fischer-fröhlich C, Kutschmann M, Schmidtmann I, Kirste G. Joint Impact of Donor and Recipient Parameters on the Outcome of Liver Transplantation in Germany. Transplantation 2011;92:1378-84. [DOI: 10.1097/tp.0b013e318236cd2f] [Cited by in Crossref: 25] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
87 Eichelmann AK, Vogel T, Fuchs AK, Houben P, Katou S, Becker F, Schmidt HH, Wilms C, Pascher A, Brockmann JG. Short- and Long-Term Outcomes of Different Reperfusion Sequences in Liver Transplantation. Ann Transplant 2021;26:e926847. [PMID: 33602890 DOI: 10.12659/AOT.926847] [Reference Citation Analysis]
88 Cruz-ramı´rez M, Hervás-martı´nez C, Fernández JC, Briceño J, de la Mata M. Multi-objective evolutionary algorithm for donor–recipient decision system in liver transplants. European Journal of Operational Research 2012;222:317-27. [DOI: 10.1016/j.ejor.2012.05.013] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
89 Laurens M, Scozzari G, Patrono D, St-paul M, Gugenheim J, Huet P, Crenesse D. Warm ischemia-reperfusion injury is decreased by tacrolimus in steatotic rat liver. Liver Transpl 2006;12:217-25. [DOI: 10.1002/lt.20585] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.0] [Reference Citation Analysis]
90 Dutkowski P, Linecker M, Deoliveira ML, Müllhaupt B, Clavien P. Challenges to Liver Transplantation and Strategies to Improve Outcomes. Gastroenterology 2015;148:307-23. [DOI: 10.1053/j.gastro.2014.08.045] [Cited by in Crossref: 135] [Cited by in F6Publishing: 134] [Article Influence: 19.3] [Reference Citation Analysis]
91 Radunz S, Paul A, Nowak K, Treckmann JW, Saner FH, Mathé Z. Liver transplantation using donor organs with markedly elevated liver enzymes: how far can we go?: Donor livers with elevated liver enzymes. Liver International 2011;31:1021-7. [DOI: 10.1111/j.1478-3231.2011.02525.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
92 Nonthasoot B, Tongyoo A, Sirichindakul B, Nivatvongs S, Suphapol J, Leelanukrom R, Poonyathawon S, Burimsittichai R, Wisedopas N, Komolmit P. Favorable outcome of orthotopic liver transplantation in very high-risk situations. Transplant Proc 2008;40:3571-3. [PMID: 19100441 DOI: 10.1016/j.transproceed.2008.06.068] [Reference Citation Analysis]
93 Fan L, Fu Z, Xiong Y, Ye S, Wang Y, Peng G, Ye Q. Double-lobectomy in a steatotic liver transplantation rat model. Exp Ther Med 2021;21:256. [PMID: 33603863 DOI: 10.3892/etm.2021.9687] [Reference Citation Analysis]
94 Vos JJ, Wietasch JK, Absalom AR, Hendriks HG, Scheeren TW. Green light for liver function monitoring using indocyanine green? An overview of current clinical applications. Anaesthesia. 2014;69:1364-1376. [PMID: 24894115 DOI: 10.1111/anae.12755] [Cited by in Crossref: 38] [Cited by in F6Publishing: 32] [Article Influence: 4.8] [Reference Citation Analysis]
95 Núñez KG, Frank A, Gonzalez-Rosario J, Galliano G, Bridle K, Crawford D, Seal J, Abbruscato F, Vashistha H, Thevenot PT, Cohen AJ. Interleukin-33 / Cyclin D1 imbalance in severe liver steatosis predicts susceptibility to ischemia reperfusion injury. PLoS One 2019;14:e0216242. [PMID: 31034519 DOI: 10.1371/journal.pone.0216242] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
96 Cescon M, Grazi GL, Cucchetti A, Ravaioli M, Ercolani G, Vivarelli M, D'Errico A, Del Gaudio M, Pinna AD. Improving the outcome of liver transplantation with very old donors with updated selection and management criteria. Liver Transpl. 2008;14:672-679. [PMID: 18433035 DOI: 10.1002/lt.21433] [Cited by in Crossref: 72] [Cited by in F6Publishing: 65] [Article Influence: 5.1] [Reference Citation Analysis]
97 Nakamura K, Kageyama S, Kupiec-Weglinski JW. The Evolving Role of Neutrophils in Liver Transplant Ischemia-Reperfusion Injury. Curr Transplant Rep 2019;6:78-89. [PMID: 31602356 DOI: 10.1007/s40472-019-0230-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
98 Pezzati D, Ghinolfi D, De Simone P, Balzano E, Filipponi F. Strategies to optimize the use of marginal donors in liver transplantation. World J Hepatol 2015; 7(26): 2636-2647 [PMID: 26609341 DOI: 10.4254/wjh.v7.i26.2636] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 3.3] [Reference Citation Analysis]
99 Kueht M, Goss JA, Rana A. Adding to the mounting evidence for geographic inequity in liver transplantation: Hospital length of stay. Clin Transplant 2018;32:e13336. [PMID: 29947035 DOI: 10.1111/ctr.13336] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
100 Ojo A, Luan F, Sung RS, Merion RM. The use of expanded criteria donor organs for transplantation. Transplantation Reviews 2006;20:41-8. [DOI: 10.1016/j.trre.2006.02.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
101 Halazun KJ, Rana AA, Fortune B, Quillin RC 3rd, Verna EC, Samstein B, Guarrera JV, Kato T, Griesemer AD, Fox A, Brown RS Jr, Emond JC. No country for old livers? Examining and optimizing the utilization of elderly liver grafts. Am J Transplant. 2018;18:669-678. [PMID: 28960723 DOI: 10.1111/ajt.14518] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 5.2] [Reference Citation Analysis]
102 Akamatsu N, Sugawara Y, Tamura S, Kaneko J, Matsui Y, Togashi J, Makuuchi M. Impact of live donor age on liver transplantation. Transplant Proc. 2007;39:3189-3193. [PMID: 18089350 DOI: 10.1016/j.transproceed.2007.03.116] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 2.0] [Reference Citation Analysis]
103 Corradini SG, Micheletta F, Natoli S, Iappelli M, Di Angelantonio E, De Marco R, Elisei W, Siciliano M, Rossi M, Berloco P, Attili AF, Diczfalusy U, Iuliano L. High preoperative recipient plasma 7β-hydroxycholesterol is associated with initial poor graft function after liver transplantation. Liver Transpl 2005;11:1494-504. [DOI: 10.1002/lt.20524] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
104 Wu B, Wu H, Chen J, Hua X, Li N, Lu M. Comparative proteomic analysis of human donor tissues during orthotopic liver transplantation: ischemia versus reperfusion. Hepatol Int 2013;7:286-98. [PMID: 26201644 DOI: 10.1007/s12072-012-9346-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
105 Amatschek S, Wilflingseder J, Pones M, Kainz A, Bodingbauer M, Mühlbacher F, Langer RM, Gerlei Z, Oberbauer R. The effect of steroid pretreatment of deceased organ donors on liver allograft function: a blinded randomized placebo-controlled trial. J Hepatol 2012;56:1305-9. [PMID: 22326464 DOI: 10.1016/j.jhep.2012.01.020] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 2.1] [Reference Citation Analysis]
106 Tai K, Kuramitsu K, Kido M, Tanaka M, Komatsu S, Awazu M, Gon H, So S, Tsugawa D, Mukubo H, Terai S, Yanagimoto H, Toyama H, Ajiki T, Fukumoto T. Impact of Albumin-Bilirubin Score on Short- and Long-Term Survival After Living-Donor Liver Transplantation: A Retrospective Study. Transplant Proc 2020;52:910-9. [PMID: 32183990 DOI: 10.1016/j.transproceed.2020.01.020] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
107 Amin MG, Wolf MP, Tenbrook JA, Freeman RB, Cheng SJ, Pratt DS, Wong JB. Expanded criteria donor grafts for deceased donor liver transplantation under the MELD system: A decision analysis. Liver Transpl 2004;10:1468-75. [DOI: 10.1002/lt.20304] [Cited by in Crossref: 86] [Cited by in F6Publishing: 78] [Article Influence: 4.8] [Reference Citation Analysis]
108 Jiménez-Romero C, Manrique A, Calvo J, Caso Ó, Marcacuzco A, García-Sesma Á, Abradelo M, Nutu A, García-Conde M, San Juan R, Justo I. Liver Transplantation Using Uncontrolled Donors After Circulatory Death: A 10-year Single-center Experience. Transplantation 2019;103:2497-505. [PMID: 31765364 DOI: 10.1097/TP.0000000000002780] [Cited by in Crossref: 14] [Cited by in F6Publishing: 3] [Article Influence: 7.0] [Reference Citation Analysis]
109 Kageyama S, Yagi S, Tanaka H, Saito S, Nagai K, Hata K, Fujimoto Y, Ogura Y, Tolba R, Shinji U. Graft reconditioning with nitric oxide gas in rat liver transplantation from cardiac death donors. Transplantation. 2014;97:618-625. [PMID: 24521773 DOI: 10.1097/tp.0000000000000025] [Cited by in Crossref: 14] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
110 Vekemans K, Liu Q, Heedfeld V, Van de Vel K, Wylin T, Pirenne J, Monbaliu D. Hypothermic Liver Machine Perfusion With EKPS-1 Solution vs Aqix RS-I Solution: In Vivo Feasibility Study in a Pig Transplantation Model. Transplant Proc. 2009;41:617-621. [PMID: 19328939 DOI: 10.1016/j.transproceed.2008.12.022] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
111 Ghinolfi D, De Simone P, Pezzati D, Cirillo G, Filipponi F. Reply. Liver Transpl 2016;22:1303. [PMID: 27197627 DOI: 10.1002/lt.24481] [Reference Citation Analysis]
112 Sapisochin G, Bruix J. Liver transplantation for hepatocellular carcinoma: outcomes and novel surgical approaches. Nat Rev Gastroenterol Hepatol. 2017;14:203-217. [PMID: 28053342 DOI: 10.1038/nrgastro.2016.193] [Cited by in Crossref: 146] [Cited by in F6Publishing: 145] [Article Influence: 29.2] [Reference Citation Analysis]
113 Tang Z, Loss G, Carmody I, Cohen AJ. TIMP-3 Ameliorates Hepatic Ischemia/Reperfusion Injury Through Inhibition of Tumor Necrosis Factor-Alpha-Converting Enzyme Activity in Rats. Transplantation 2006;82:1518-23. [DOI: 10.1097/01.tp.0000243381.41777.c7] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
114 Beal EW, Kim JL, Reader BF, Akateh C, Maynard K, Washburn WK, Zweier JL, Whitson BA, Black SM. [D-Ala2, D-Leu5] Enkephalin Improves Liver Preservation During Normothermic Ex Vivo Perfusion. J Surg Res. 2019;241:323-335. [PMID: 31071481 DOI: 10.1016/j.jss.2019.04.010] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
115 Conti A, Scala S, D'agostino P, Alimenti E, Morelli D, Andria B, Tammaro A, Attanasio C, Ragione FD, Scuderi V, Fabbrini F, D'esposito M, Di Florio E, Nitsch L, Calise F, Faiella A. Wide gene expression profiling of ischemia-reperfusion injury in human liver transplantation. Liver Transpl 2007;13:99-113. [DOI: 10.1002/lt.20960] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 2.0] [Reference Citation Analysis]
116 He XS, Ma Y, Wu LW, Wu JL, Hu RD, Chen GH, Huang JF. Dynamical changing patterns of glycogen and enzyme histochemical activities in rat liver graft undergoing warm ischemia injury. World J Gastroenterol 2005; 11(17): 2662-2665 [PMID: 15849830 DOI: 10.3748/wjg.v11.i17.2662] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
117 Kristo I, Wilflingseder J, Kainz A, Marschalek J, Wekerle T, Mühlbacher F, Oberbauer R, Bodingbauer M. Effect of intraportal infusion of tacrolimus on ischaemic reperfusion injury in orthotopic liver transplantation: a randomized controlled trial. Transpl Int 2011;24:912-9. [PMID: 21672049 DOI: 10.1111/j.1432-2277.2011.01284.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
118 Bachir NM, Larson AM. Adult liver transplantation in the United States. Am J Med Sci. 2012;343:462-469. [PMID: 22683615 DOI: 10.1097/maj.0b013e3182308b66] [Cited by in Crossref: 23] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
119 Massip-Salcedo M, Roselló-Catafau J, Prieto J, Avíla MA, Peralta C. The response of the hepatocyte to ischemia. Liver Int. 2007;27:6-16. [PMID: 17241376 DOI: 10.1111/j.1478-3231.2006.01390.x] [Cited by in Crossref: 61] [Cited by in F6Publishing: 57] [Article Influence: 4.1] [Reference Citation Analysis]
120 Banan B, Chapman W. Promise of Normothermia. Curr Transpl Rep 2017;4:42-51. [DOI: 10.1007/s40472-017-0137-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
121 Xu J, Casas-Ferreira AM, Ma Y, Sen A, Kim M, Proitsi P, Shkodra M, Tena M, Srinivasan P, Heaton N, Jassem W, Legido-Quigley C. Lipidomics comparing DCD and DBD liver allografts uncovers lysophospholipids elevated in recipients undergoing early allograft dysfunction. Sci Rep 2015;5:17737. [PMID: 26635289 DOI: 10.1038/srep17737] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
122 Briceño J, Cruz-Ramírez M, Prieto M, Navasa M, Ortiz de Urbina J, Orti R, Gómez-Bravo MÁ, Otero A, Varo E, Tomé S, Clemente G, Bañares R, Bárcena R, Cuervas-Mons V, Solórzano G, Vinaixa C, Rubín A, Colmenero J, Valdivieso A, Ciria R, Hervás-Martínez C, de la Mata M. Use of artificial intelligence as an innovative donor-recipient matching model for liver transplantation: results from a multicenter Spanish study. J Hepatol 2014;61:1020-8. [PMID: 24905493 DOI: 10.1016/j.jhep.2014.05.039] [Cited by in Crossref: 47] [Cited by in F6Publishing: 38] [Article Influence: 5.9] [Reference Citation Analysis]
123 de Oliveira GR, Sankarankutty AK, Castro e Silva O, Ferreira J, Kurachi C, Zucoloto S, Vannucchi H, Jordão AA, Marchini JS, Bagnato VS. Fluorescence spectroscopy to diagnose hepatic steatosis in a rat model of fatty liver. Liver International 2009;29:331-6. [DOI: 10.1111/j.1478-3231.2008.01878.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
124 Jiménez-Castro MB, Cornide-Petronio ME, Gracia-Sancho J, Casillas-Ramírez A, Peralta C. Mitogen Activated Protein Kinases in Steatotic and Non-Steatotic Livers Submitted to Ischemia-Reperfusion. Int J Mol Sci 2019;20:E1785. [PMID: 30974915 DOI: 10.3390/ijms20071785] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
125 Esteban-Zubero E, García-Gil FA, López-Pingarrón L, Alatorre-Jiménez MA, Ramírez JM, Tan DX, García JJ, Reiter RJ. Melatonin role preventing steatohepatitis and improving liver transplantation results. Cell Mol Life Sci 2016;73:2911-27. [PMID: 27022943 DOI: 10.1007/s00018-016-2185-2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
126 Cruz-ramírez M, Hervás-martínez C, Fernández JC, Briceño J, de la Mata M. Predicting patient survival after liver transplantation using evolutionary multi-objective artificial neural networks. Artificial Intelligence in Medicine 2013;58:37-49. [DOI: 10.1016/j.artmed.2013.02.004] [Cited by in Crossref: 30] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
127 Bardallo RG, da Silva RT, Carbonell T, Folch-Puy E, Palmeira C, Roselló-Catafau J, Pirenne J, Adam R, Panisello-Roselló A. Role of PEG35, Mitochondrial ALDH2, and Glutathione in Cold Fatty Liver Graft Preservation: An IGL-2 Approach. Int J Mol Sci 2021;22:5332. [PMID: 34069402 DOI: 10.3390/ijms22105332] [Reference Citation Analysis]
128 Siniscalchi A, Gamberini L, Laici C, Bardi T, Ercolani G, Lorenzini L, Faenza S. Post reperfusion syndrome during liver transplantation: From pathophysiology to therapy and preventive strategies. World J Gastroenterol 2016; 22(4): 1551-1569 [PMID: 26819522 DOI: 10.3748/wjg.v22.i4.1551] [Cited by in CrossRef: 44] [Cited by in F6Publishing: 34] [Article Influence: 7.3] [Reference Citation Analysis]
129 Kim PT, Testa G. Living donor liver transplantation in the USA. Hepatobiliary Surg Nutr. 2016;5:133-140. [PMID: 27115007 DOI: 10.3978/j.issn.2304-3881.2015.06.01] [Cited by in F6Publishing: 14] [Reference Citation Analysis]
130 Jain A, Orloff M, Abt P, Kashyap R, Mohanka R, Lansing K, Bozorgzadeh A. Transplantation of Liver Grafts From Older Donors: Impact on Recipients With Hepatitis C Virus Infection. Transplantation Proceedings 2005;37:3162-4. [DOI: 10.1016/j.transproceed.2005.07.050] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
131 Farkas S, Bolder U, Schlittenbauer T, Obed A, Zuelke C, Anthuber M, Geissler E, Schlitt H. Conditioning of liver grafts with prostaglandins improves bile acid transport. Transplantation Proceedings 2005;37:435-8. [DOI: 10.1016/j.transproceed.2004.12.299] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
132 Teperman L. Donor-transmitted diseases. Liver Transpl 2010;16:S40-4. [DOI: 10.1002/lt.22153] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
133 Rabelo AV, Bastante MD, Raya AM, Méndez CS, Ramirez AR, Suarez YF. Liver Transplantation Results by Donor Age. Transplant Proc 2016;48:2994-6. [PMID: 27932128 DOI: 10.1016/j.transproceed.2016.09.023] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
134 Renz JF, Kin C, Kinkhabwala M, Jan D, Varadarajan R, Goldstein M, Brown R, Emond JC. Utilization of extended donor criteria liver allografts maximizes donor use and patient access to liver transplantation. Ann Surg. 2005;242:556-563; discussion 563-565. [PMID: 16192816 DOI: 10.1097/01.sla.0000183973.49899.b1] [Cited by in Crossref: 49] [Cited by in F6Publishing: 67] [Article Influence: 2.9] [Reference Citation Analysis]
135 Xia W, Ke Q, Wang Y, Feng X, Guo H, Wang W, Zhang M, Shen Y, Wu J, Xu X, Yan S, Zheng S. Donation after cardiac death liver transplantation: Graft quality evaluation based on pretransplant liver biopsy. Liver Transpl 2015;21:838-46. [PMID: 25824672 DOI: 10.1002/lt.24123] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
136 Spetzler V, Goldaracena N, Kaths JM, Marquez M, Selzner M, Selzner N. Elevated Preoperative Serum Bilirubin Improves Reperfusion Injury and Survival Postliver Transplantation. Transplant Direct 2017;3:e187. [PMID: 28795139 DOI: 10.1097/TXD.0000000000000684] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
137 Ikegami T, Shimada M, Imura S, Arakawa Y, Nii A, Morine Y, Kanemura H. Current concept of small-for-size grafts in living donor liver transplantation. Surg Today. 2008;38:971-982. [PMID: 18958553 DOI: 10.1007/s00595-008-3771-1] [Cited by in Crossref: 59] [Cited by in F6Publishing: 59] [Article Influence: 4.2] [Reference Citation Analysis]
138 Sharkey FE, Lytvak I, Prihoda TJ, Speeg KV, Washburn WK, Halff GA. High-grade microsteatosis and delay in hepatic function after orthotopic liver transplantation. Hum Pathol 2011;42:1337-42. [PMID: 21420717 DOI: 10.1016/j.humpath.2010.12.004] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
139 McCormack L, Petrowsky H, Jochum W, Mullhaupt B, Weber M, Clavien PA. Use of severely steatotic grafts in liver transplantation: a matched case-control study. Ann Surg. 2007;246:940-946; discussion 946-948. [PMID: 18043095 DOI: 10.1097/sla.0b013e31815c2a3f] [Cited by in Crossref: 182] [Cited by in F6Publishing: 47] [Article Influence: 13.0] [Reference Citation Analysis]
140 Chino F, Stephens SJ, Choi SS, Marin D, Kim CY, Morse MA, Godfrey DJ, Czito BG, Willett CG, Palta M. The role of external beam radiotherapy in the treatment of hepatocellular cancer. Cancer. 2018;124:3476-3489. [PMID: 29645076 DOI: 10.1002/cncr.31334] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
141 Geenen ILA, Sosef MN, Shun A, Crawford M, Gallagher J, Strasser S, Stormon M, Mccaughan G, Verran DJ. Usage and outcomes of deceased donor liver allografts with preprocurement injury from blunt trauma: Preprocurement Injury from Blunt Trauma. Liver Transpl 2009;15:321-5. [DOI: 10.1002/lt.21687] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
142 da Silva CG, Cervantes JR, Studer P, Ferran C. A20-An Omnipotent Protein in the Liver: Prometheus Myth Resolved? In: Ferran C, editor. The Multiple Therapeutic Targets of A20. New York: Springer; 2014. pp. 117-39. [DOI: 10.1007/978-1-4939-0398-6_8] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
143 Díaz Jaime F, Berenguer M. Pushing the donor limits: Deceased donor liver transplantation using organs from octogenarian donors: Supplement. Liver Transpl 2017;23:S22-6. [DOI: 10.1002/lt.24841] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
144 Cesaratto L, Vascotto C, D'ambrosio C, Scaloni A, Baccarani U, Paron I, Damante G, Calligaris S, Quadrifoglio F, Tiribelli C, Tell G. Overoxidation of peroxiredoxins as an immediate and sensitive marker of oxidative stress in HepG2 cells and its application to the redox effects induced by ischemia/reperfusion in human liver. Free Radical Research 2009;39:255-68. [DOI: 10.1080/10715760400029603] [Cited by in Crossref: 50] [Cited by in F6Publishing: 51] [Article Influence: 3.8] [Reference Citation Analysis]
145 Liu Q, Rehman H, Krishnasamy Y, Ramshesh VK, Theruvath TP, Chavin KD, Schnellmann RG, Lemasters JJ, Zhong Z. Role of inducible nitric oxide synthase in mitochondrial depolarization and graft injury after transplantation of fatty livers. Free Radic Biol Med 2012;53:250-9. [PMID: 22609250 DOI: 10.1016/j.freeradbiomed.2012.05.012] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
146 Alwayn IP, Andersson C, Zauscher B, Gura K, Nosé V, Puder M. Omega-3 fatty acids improve hepatic steatosis in a murine model: potential implications for the marginal steatotic liver donor. Transplantation. 2005;79:606-608. [PMID: 15753852 DOI: 10.1097/01.tp.0000150023.86487.44] [Cited by in Crossref: 55] [Cited by in F6Publishing: 19] [Article Influence: 3.2] [Reference Citation Analysis]
147 Battula N, Reichman TW, Amiri Y, Carmody IC, Galliano G, Seal J, Bugeaud E, Bohorquez H, Bruce D, Cohen A, Loss GE. Outcomes utilizing imported liver grafts for recipients with hepatocellular carcinoma. Liver Transpl 2017;23:299-304. [PMID: 28026108 DOI: 10.1002/lt.24709] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
148 García-Gil FA, Albendea CD, López-Pingarrón L, Royo-Dachary P, Martínez-Guillén J, Piedrafita E, Martínez-Díez M, Soria J, García JJ. Altered cellular membrane fluidity levels and lipid peroxidation during experimental pancreas transplantation. J Bioenerg Biomembr. 2012;44:571-577. [PMID: 22986734 DOI: 10.1007/s10863-012-9459-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
149 Cameron A, Busuttil RW. AASLD/ILTS transplant course: Is there an extended donor suitable for everyone? Liver Transpl 2005;11:S2-5. [DOI: 10.1002/lt.20596] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 2.3] [Reference Citation Analysis]
150 Ravaioli M, Grazi GL, Ercolani G, Cescon M, Pinna AD, Ballardini G. The Future Challenge in the MELD Era: How to Match Extended-Use Donors and Sick Recipients. Transplantation 2006;82:987-8. [DOI: 10.1097/01.tp.0000238705.29588.fc] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
151 Abouna GM. Organ shortage crisis: problems and possible solutions. Transplant Proc. 2008;40:34-38. [PMID: 18261540 DOI: 10.1016/j.transproceed.2007.11.067] [Cited by in Crossref: 195] [Cited by in F6Publishing: 159] [Article Influence: 13.9] [Reference Citation Analysis]
152 Angulo P. Nonalcoholic fatty liver disease and liver transplantation. Liver Transpl. 2006;12:523-534. [PMID: 16555318 DOI: 10.1002/lt.20738] [Cited by in Crossref: 104] [Cited by in F6Publishing: 97] [Article Influence: 6.5] [Reference Citation Analysis]
153 Nostedt JJ, Skubleny DT, Shapiro AMJ, Campbell S, Freed DH, Bigam DL. Normothermic Ex Vivo Machine Perfusion for Liver Grafts Recovered from Donors after Circulatory Death: A Systematic Review and Meta-Analysis. HPB Surg. 2018;2018:6867986. [PMID: 29849531 DOI: 10.1155/2018/6867986] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
154 Ballarin R, Cucchetti A, Russo FP, Magistri P, Cescon M, Cillo U, Burra P, Pinna AD, Di Benedetto F. Long term follow-up and outcome of liver transplantation from hepatitis B surface antigen positive donors. World J Gastroenterol 2017; 23(12): 2095-2105 [PMID: 28405138 DOI: 10.3748/wjg.v23.i12.2095] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
155 Casale F, Lupo F, Passera R, Liddo G, Moscato D, Mosso R, Zara GP, Eandi M, Salizzoni M. Pharmacokinetics of cyclosporine in recipients of marginal versus standard liver transplants. Pharmacol Res 2006;54:287-92. [PMID: 16884914 DOI: 10.1016/j.phrs.2006.06.004] [Reference Citation Analysis]
156 Wang CC, Wang SH, Lin CC, Liu YW, Yong CC, Yang CH, Huang KC, Lin TS, Jawan B, Cheng YF, Eng HL, Concejero AM, Chen CL. Liver transplantation from an uncontrolled non-heart-beating donor maintained on extracorporeal membrane oxygenation. Transplant Proc. 2005;37:4331-4333. [PMID: 16387112 DOI: 10.1016/j.transproceed.2005.11.013] [Cited by in Crossref: 25] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
157 Carpenter DJ, Chiles MC, Verna EC, Halazun KJ, Emond JC, Ratner LE, Mohan S. Deceased Brain Dead Donor Liver Transplantation and Utilization in the United States: Nighttime and Weekend Effects. Transplantation 2019;103:1392-404. [PMID: 30444802 DOI: 10.1097/TP.0000000000002533] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
158 Lucena O, Amorim AG, Sabat B, Adeodato LCL, Miranda LEC, Lacerda CM. Transplante de fígado a partir de doadores em assistolia: resultados iniciais do grupo de transplante de fígado do Hospital Oswaldo Cruz, Universidade de Pernambuco. Rev Col Bras Cir 2005;32:270-2. [DOI: 10.1590/s0100-69912005000500010] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
159 Flechtenmacher C, Schirmacher P, Schemmer P. Donor liver histology—a valuable tool in graft selection. Langenbecks Arch Surg 2015;400:551-7. [DOI: 10.1007/s00423-015-1298-7] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
160 Hide D, Ortega-Ribera M, Fernández-Iglesias A, Fondevila C, Salvadó MJ, Arola L, García-Pagán JC, Mancini A, Bosch J, Gracia-Sancho J. A novel form of the human manganese superoxide dismutase protects rat and human livers undergoing ischaemia and reperfusion injury. Clin Sci (Lond) 2014;127:527-37. [PMID: 24754522 DOI: 10.1042/CS20140125] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 2.1] [Reference Citation Analysis]
161 Casillas-Ramírez A, Mosbah IB, Franco-Gou R, Rimola A, Roselló-Catafau J, Peralta C. [Ischemia-reperfusion syndrome associated with liver transplantation: an update]. Gastroenterol Hepatol 2006;29:306-13. [PMID: 16733038 DOI: 10.1157/13087472] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
162 Justo I, Nutu A, García-Conde M, Marcacuzco A, Manrique A, Calvo J, García-Sesma Á, Caso Ó, Martín-Arriscado C, Andrés A, Paz E, Jiménez-Romero C. Incidence and risk factors of primary non-function after liver transplantation using grafts from uncontrolled donors after circulatory death. Clin Transplant 2021;35:e14134. [PMID: 33128296 DOI: 10.1111/ctr.14134] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
163 Wang Y, Yang Y, Wang M, Wang S, Jeong JM, Xu L, Wen Y, Emontzpohl C, Atkins CL, Duong K, Moreno NF, Yuan X, Hall DR, Dar W, Feng D, Gao B, Xu Y, Czigany Z, Colgan SP, Bynon JS, Akira S, Brown JM, Eltzschig HK, Jacobsen EA, Ju C. Eosinophils attenuate hepatic ischemia-reperfusion injury in mice through ST2-dependent IL-13 production. Sci Transl Med 2021;13:eabb6576. [PMID: 33536281 DOI: 10.1126/scitranslmed.abb6576] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
164 Olthoff KM, Merion RM, Ghobrial RM, Abecassis MM, Fair JH, Fisher RA, Freise CE, Kam I, Pruett TL, Everhart JE, Hulbert-Shearon TE, Gillespie BW, Emond JC; A2ALL Study Group. Outcomes of 385 adult-to-adult living donor liver transplant recipients: a report from the A2ALL Consortium. Ann Surg 2005;242:314-23, discussion 323-5. [PMID: 16135918 DOI: 10.1097/01.sla.0000179646.37145.ef] [Cited by in Crossref: 75] [Cited by in F6Publishing: 125] [Article Influence: 4.4] [Reference Citation Analysis]
165 Mazza G, Rombouts K, Rennie Hall A, Urbani L, Vinh Luong T, Al-Akkad W, Longato L, Brown D, Maghsoudlou P, Dhillon AP, Fuller B, Davidson B, Moore K, Dhar D, De Coppi P, Malago M, Pinzani M. Decellularized human liver as a natural 3D-scaffold for liver bioengineering and transplantation. Sci Rep. 2015;5:13079. [PMID: 26248878 DOI: 10.1038/srep13079] [Cited by in Crossref: 235] [Cited by in F6Publishing: 205] [Article Influence: 33.6] [Reference Citation Analysis]
166 Pérez-ortiz M, Gutiérrez P, Ayllón-terán M, Heaton N, Ciria R, Briceño J, Hervás-martínez C. Synthetic semi-supervised learning in imbalanced domains: Constructing a model for donor-recipient matching in liver transplantation. Knowledge-Based Systems 2017;123:75-87. [DOI: 10.1016/j.knosys.2017.02.020] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 1.2] [Reference Citation Analysis]
167 Kawahara T, Toso C, Douglas DN, Nourbakhsh M, Lewis JT, Tyrrell DL, Lund GA, Churchill TA, Kneteman NM. Factors affecting hepatocyte isolation, engraftment, and replication in an in vivo model. Liver Transpl. 2010;16:974-982. [PMID: 20677288 DOI: 10.1002/lt.22099] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 3.1] [Reference Citation Analysis]
168 Segev DL, Kucirka LM, Nguyen GC, Cameron AM, Locke JE, Simpkins CE, Thuluvath PJ, Montgomery RA, Maley WR. Effect modification in liver allografts with prolonged cold ischemic time. Am J Transplant 2008;8:658-66. [PMID: 18294162 DOI: 10.1111/j.1600-6143.2007.02108.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
169 Biancofiore G, Bindi M, Ghinolfi D, Lai Q, Bisa M, Esposito M, Meacci L, Mozzo R, Spelta A, Filipponi F. Octogenarian donors in liver transplantation grant an equivalent perioperative course to ideal young donors. Dig Liver Dis 2017;49:676-82. [PMID: 28179097 DOI: 10.1016/j.dld.2017.01.149] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
170 Zaky A, Pretto EA, Earle SA, Piraccini E, Zuccarelli JE, Arheart KL, Proctor KG. Hemodynamic and metabolic efficacy of dopamine versus norepinephrine in a brain-dead swine model. Liver Transpl 2008;14:1266-72. [DOI: 10.1002/lt.21535] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
171 Schneider S, Díaz Jaime F, Mara K, Dierkhising R, Heimbach J, Watt KD, Berenguer M. Long‐term outcomes of the octogenarian donor liver recipient: The era of the new centurion. Clin Transplant 2019;33. [DOI: 10.1111/ctr.13629] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
172 Roels L, Rahmel A. The European experience. Transpl Int. 2011;24:350-367. [PMID: 21265886 DOI: 10.1111/j.1432-2277.2011.01225.x] [Cited by in Crossref: 41] [Cited by in F6Publishing: 34] [Article Influence: 3.7] [Reference Citation Analysis]
173 Corradini SG, Elisei W, De Marco R, Siciliano M, Iappelli M, Pugliese F, Ruberto F, Nudo F, Pretagostini R, Bussotti A, Mennini G, Eramo A, Liguori F, Merli M, Attili AF, Muda AO, Natalizi S, Berloco P, Rossi M. Preharvest donor hyperoxia predicts good early graft function and longer graft survival after liver transplantation. Liver Transpl 2005;11:140-51. [DOI: 10.1002/lt.20339] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
174 Briceño J, Ciria R. Early graft dysfunction after liver transplantation. Transplant Proc 2010;42:631-3. [PMID: 20304210 DOI: 10.1016/j.transproceed.2010.02.004] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 3.0] [Reference Citation Analysis]
175 Mawardi M, Aba Alkhail F, Katada K, Levstik M, Quan D, Wall W, Marotta P, Hernandezalejandro R. The clinical consequences of utilizing donation after cardiac death liver grafts into hepatitis C recipients. Hepatol Int 2011;5:830-3. [DOI: 10.1007/s12072-010-9242-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
176 Tector AJ, Mangus RS, Chestovich P, Vianna R, Fridell JA, Milgrom ML, Sanders C, Kwo PY. Use of extended criteria livers decreases wait time for liver transplantation without adversely impacting posttransplant survival. Ann Surg. 2006;244:439-450. [PMID: 16926570 DOI: 10.1097/01.sla.0000234896.18207.fa] [Cited by in Crossref: 56] [Cited by in F6Publishing: 71] [Article Influence: 3.5] [Reference Citation Analysis]
177 Michelotto J, Gassner JMGV, Moosburner S, Muth V, Patel MS, Selzner M, Pratschke J, Sauer IM, Raschzok N. Ex vivo machine perfusion: current applications and future directions in liver transplantation. Langenbecks Arch Surg 2021;406:39-54. [PMID: 33216216 DOI: 10.1007/s00423-020-02014-7] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
178 Park PJ, Yu YD, Yoon YI, Kim SR, Kim DS. Single-Center Experience Using Marginal Liver Grafts in Korea. Transplant Proc 2018;50:1147-52. [PMID: 29731083 DOI: 10.1016/j.transproceed.2018.01.040] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
179 Demetris A, Crawford JM, Minervini MI, Nalesnik M, Ochoa E, Randhawa P, Sasatomi E, Wu T. Transplantation Pathology of the Liver. Surgical Pathology of the GI Tract, Liver, Biliary Tract, and Pancreas. Elsevier; 2009. pp. 1169-229. [DOI: 10.1016/b978-141604059-0.50047-3] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
180 Onishi H, Theisen D, Dietrich O, Reiser MF, Zech CJ. Hepatic steatosis: effect on hepatocyte enhancement with gadoxetate disodium-enhanced liver MR imaging. J Magn Reson Imaging. 2014;39:42-50. [PMID: 24339365 DOI: 10.1002/jmri.24136] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
181 Farrell GC, Teoh NC, McCuskey RS. Hepatic microcirculation in fatty liver disease. Anat Rec (Hoboken). 2008;291:684-692. [PMID: 18484615 DOI: 10.1002/ar.20715] [Cited by in Crossref: 166] [Cited by in F6Publishing: 159] [Article Influence: 11.9] [Reference Citation Analysis]
182 Nissen NN, Colquhoun SD. Graft Failure: Etiology, Recognition, and Treatment. Transplantation of the Liver. Elsevier; 2005. pp. 915-28. [DOI: 10.1016/b978-0-7216-0118-2.50066-5] [Cited by in Crossref: 7] [Article Influence: 0.4] [Reference Citation Analysis]
183 Routh D, Sharma S, Naidu CS, Rao PP, Sharma AK, Ranjan P. Comparison of outcomes in ideal donor and extended criteria donor in deceased donor liver transplant: a prospective study. Int J Surg. 2014;12:774-777. [PMID: 24947949 DOI: 10.1016/j.ijsu.2014.06.003] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
184 Müllhaupt B, Dimitroulis D, Gerlach JT, Clavien PA. Hot topics in liver transplantation: organ allocation--extended criteria donor--living donor liver transplantation. J Hepatol 2008;48 Suppl 1:S58-67. [PMID: 18308415 DOI: 10.1016/j.jhep.2008.01.013] [Cited by in Crossref: 41] [Cited by in F6Publishing: 34] [Article Influence: 2.9] [Reference Citation Analysis]
185 Li J, Liu B, Yan LN, Zuo YX, Li B, Zeng Y, Zhang SF, Li FG. Reversal of graft steatosis after liver transplantation: prospective study. Transplant Proc 2009;41:3560-3. [PMID: 19917344 DOI: 10.1016/j.transproceed.2009.06.222] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 2.7] [Reference Citation Analysis]
186 Ho CM, Lee PH, Cheng WT, Hu RH, Wu YM, Ho MC. Succinct guide to liver transplantation for medical students. Ann Med Surg (Lond) 2016;12:47-53. [PMID: 27895907 DOI: 10.1016/j.amsu.2016.11.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
187 Choi WT, Jen KY, Wang D, Tavakol M, Roberts JP, Gill RM. Donor Liver Small Droplet Macrovesicular Steatosis Is Associated With Increased Risk for Recipient Allograft Rejection. Am J Surg Pathol 2017;41:365-73. [PMID: 28059835 DOI: 10.1097/PAS.0000000000000802] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 2.8] [Reference Citation Analysis]
188 Dasari BVM, Schlegel A, Mergental H, Perera MTPR. The use of old donors in liver transplantation. Best Pract Res Clin Gastroenterol. 2017;31:211-217. [PMID: 28624109 DOI: 10.1016/j.bpg.2017.03.002] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 4.4] [Reference Citation Analysis]
189 Broering DC, Walter J, Braun F, Rogiers X. Current Status of Hepatic Transplantation. Current Problems in Surgery 2008;45:587-661. [DOI: 10.1067/j.cpsurg.2008.05.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
190 Soyer V, Koc S, Onur A, Sarıcı B, Kayaalp C, Isık B, Unal B, Yologlu S, Yilmaz S. Futility Versus Acceptability of the Use of Grafts Taken From End of Line in the National Organ-Sharing Network. Transplantation Proceedings 2015;47:1257-61. [DOI: 10.1016/j.transproceed.2015.04.067] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
191 Zhang T, Dunson J, Kanwal F, Galvan NTN, Vierling JM, O'Mahony C, Goss JA, Rana A. Trends in Outcomes for Marginal Allografts in Liver Transplant. JAMA Surg 2020. [PMID: 32777009 DOI: 10.1001/jamasurg.2020.2484] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
192 Mangus RS, Borup TC, Popa S, Saxena R, Cummings O, Tector AJ. Utility of pre-procurement bedside liver biopsy in the deceased extended-criteria liver donor. Clin Transplant. 2014;28:1358-1364. [PMID: 25203789 DOI: 10.1111/ctr.12461] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
193 Baskin-Bey ES, Canbay A, Bronk SF, Werneburg N, Guicciardi ME, Nyberg SL, Gores GJ. Cathepsin B inactivation attenuates hepatocyte apoptosis and liver damage in steatotic livers after cold ischemia-warm reperfusion injury. Am JPhysiol Gastrointest Liver Physiol. 2005;288:G396-G402. [PMID: 15472011 DOI: 10.1152/ajpgi.00316.2004] [Cited by in Crossref: 71] [Cited by in F6Publishing: 70] [Article Influence: 3.9] [Reference Citation Analysis]
194 Ma Y, Wang GD, Wu LW, Hu RD. Dynamical changing patterns of histological structure and ultrastructure of liver graft undergoing warm ischemia injury from non-heart-beating donor in rats. World J Gastroenterol 2006; 12(30): 4902-4905 [PMID: 16937478 DOI: 10.3748/wjg.v12.i30.4902] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
195 White SA, Prasad KR. Liver transplantation from non-heart beating donors. BMJ. 2006;332:376-377. [PMID: 16484243 DOI: 10.1136/bmj.332.7538.376] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]
196 Pokorny H, Langer F, Herkner H, Schernberger R, Plochl W, Soliman T, Steininger R, Muehlbacher F. Influence of cumulative number of marginal donor criteria on primary organ dysfunction in liver recipients. Clin Transplant 2005;19:532-6. [DOI: 10.1111/j.1399-0012.2005.00384.x] [Cited by in Crossref: 58] [Cited by in F6Publishing: 46] [Article Influence: 3.4] [Reference Citation Analysis]
197 Nostedt JJ, Churchill T, Ghosh S, Thiesen A, Hopkins J, Lees MC, Adam B, Freed DH, Shapiro AMJ, Bigam DL. Avoiding initial hypothermia does not improve liver graft quality in a porcine donation after circulatory death (DCD) model of normothermic perfusion. PLoS One 2019;14:e0220786. [PMID: 31386697 DOI: 10.1371/journal.pone.0220786] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
198 Zhou ZJ, Chen GS, Si ZZ, Li Q, Bin YY, Qi HZ, Li JQ. Prognostic factors influencing outcome in adult liver transplantation using hypernatremic organ donation after brain death. Hepatobiliary Pancreat Dis Int 2020;19:371-7. [PMID: 32553773 DOI: 10.1016/j.hbpd.2020.06.003] [Reference Citation Analysis]
199 Evans ZP, Ellett JD, Fariss MW, Schnellmann RG, Schmidt MG, Chavin K. Vitamin E succinate reduces ischemia/reperfusion injury in steatotic livers. Transplant Proc 2008;40:3327-9. [PMID: 19100382 DOI: 10.1016/j.transproceed.2008.06.076] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
200 Nadalin S, Malagó M, Valentin-Gamazo C, Testa G, Baba HA, Liu C, Frühauf NR, Schaffer R, Gerken G, Frilling A. Preoperative donor liver biopsy for adult living donor liver transplantation: risks and benefits. Liver Transpl. 2005;11:980-986. [PMID: 16035060 DOI: 10.1002/lt.20462] [Cited by in Crossref: 72] [Cited by in F6Publishing: 56] [Article Influence: 4.2] [Reference Citation Analysis]
201 Arora SS, Chahal KS, Axley P, Eckhoff DE, Kuo YF, Satapathy SK, Wiesner R, Singal AK. Heavy Alcohol Use Among Deceased Donors Does Not Impact Recipient Outcomes After Liver Transplantation. Transplantation 2018;102:1864-9. [PMID: 29677070 DOI: 10.1097/TP.0000000000002230] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
202 Jiménez-Romero C, Manrique A, García-Conde M, Nutu A, Calvo J, Caso Ó, Marcacuzco A, García-Sesma Á, Álvaro E, Villar R, Aguado JM, Conde M, Justo I. Biliary Complications After Liver Transplantation From Uncontrolled Donors After Circulatory Death: Incidence, Management, and Outcome. Liver Transpl 2020;26:80-91. [PMID: 31562677 DOI: 10.1002/lt.25646] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
203 Sass DA, Reich DJ. Liver transplantation in the 21st century: expanding the donor options. Gastroenterol Clin North Am. 2011;40:641-658. [PMID: 21893278 DOI: 10.1016/j.gtc.2011.06.007] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
204 Núñez K, Thevenot P, Alfadhli A, Cohen A. Complement Activation in Liver Transplantation: Role of Donor Macrosteatosis and Implications in Delayed Graft Function. Int J Mol Sci 2018;19:E1750. [PMID: 29899265 DOI: 10.3390/ijms19061750] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
205 Vilatoba M, Eckstein C, Bilbao G, Smyth CA, Jenkins S, Thompson JA, Eckhoff DE, Contreras JL. Sodium 4-phenylbutyrate protects against liver ischemia reperfusion injury by inhibition of endoplasmic reticulum-stress mediated apoptosis. Surgery. 2005;138:342-351. [PMID: 16153446 DOI: 10.1016/j.surg.2005.04.019] [Cited by in Crossref: 103] [Cited by in F6Publishing: 99] [Article Influence: 6.1] [Reference Citation Analysis]
206 Westerkamp AC, de Boer MT, van den Berg AP, Gouw AS, Porte RJ. Similar outcome after transplantation of moderate macrovesicular steatotic and nonsteatotic livers when the cold ischemia time is kept very short. Transpl Int. 2015;28:319-329. [PMID: 25545740 DOI: 10.1111/tri.12504] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 3.6] [Reference Citation Analysis]
207 Karatas C, Alim A, Tirnova I, Akbulut A, Demir B, Kanmaz T. Urgent Liver Transplantation from Deceased Donor With a Calcified Hydatid Cyst: A Case Report. Transplant Proc 2021:S0041-1345(21)00719-3. [PMID: 34728080 DOI: 10.1016/j.transproceed.2021.08.057] [Reference Citation Analysis]
208 Zaouali MA, Bardag-Gorce F, Carbonell T, Oliva J, Pantazi E, Bejaoui M, Ben Abdennebi H, Rimola A, Roselló-Catafau J. Proteasome inhibitors protect the steatotic and non-steatotic liver graft against cold ischemia reperfusion injury. Exp Mol Pathol 2013;94:352-9. [PMID: 23305864 DOI: 10.1016/j.yexmp.2012.12.005] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 3.0] [Reference Citation Analysis]
209 Kamo N, Kaido T, Hammad A, Ogawa K, Fujimoto Y, Uemura T, Mori A, Hatano E, Okajima H, Uemoto S. Impact of elderly donors for liver transplantation: A single-center experience. Liver Transpl. 2015;21:591-598. [PMID: 25641778 DOI: 10.1002/lt.24086] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
210 Gabrielli M, Moisan F, Vidal M, Duarte I, Jiménez M, Izquierdo G, Domínguez P, Méndez J, Soza A, Benitez C, Pérez R, Arrese M, Guerra J, Jarufe N, Martínez J. Steatotic livers. Can we use them in OLTX? Outcome data from a prospective baseline liver biopsy study. Annals of Hepatology 2012;11:891-8. [DOI: 10.1016/s1665-2681(19)31415-2] [Cited by in Crossref: 37] [Article Influence: 3.7] [Reference Citation Analysis]
211 Jia D, Pan Q, Zhang Y, Yu Y, Song Z, Liu YF, Jia Z, Guo S, Cheng Y. Ischemic postconditioning improves the outcome of organs from donors after cardiac death in a pig liver transplantation model and provides synergistic protection with hypothermic machine perfusion. Clin Transplant 2021. [PMID: 34231926 DOI: 10.1111/ctr.14417] [Reference Citation Analysis]
212 Cieślak B, Lewandowski Z, Urban M, Ziarkiewicz-Wróblewska B, Krawczyk M. Microvesicular liver graft steatosis as a risk factor of initial poor function in relation to suboptimal donor parameters. Transplant Proc 2009;41:2985-8. [PMID: 19857657 DOI: 10.1016/j.transproceed.2009.08.019] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 2.3] [Reference Citation Analysis]
213 Renz JF, Yersiz H. The Donor Operation. Transplantation of the Liver. Elsevier; 2005. pp. 545-59. [DOI: 10.1016/b978-0-7216-0118-2.50042-2] [Cited by in Crossref: 7] [Article Influence: 0.4] [Reference Citation Analysis]
214 Vascotto C, Cesaratto L, D'ambrosio C, Scaloni A, Avellini C, Paron I, Baccarani U, Adani GL, Tiribelli C, Quadrifoglio F, Tell G. Proteomic analysis of liver tissues subjected to early ischemia/reperfusion injury during human orthotopic liver transplantation. Proteomics 2006;6:3455-65. [DOI: 10.1002/pmic.200500770] [Cited by in Crossref: 48] [Cited by in F6Publishing: 48] [Article Influence: 3.0] [Reference Citation Analysis]
215 Schmeding M, Heidenhain C, Neuhaus R, Neuhaus P, Neumann UP. Liver transplantation for alcohol-related cirrhosis: a single centre long-term clinical and histological follow-up. Dig Dis Sci 2011;56:236-43. [PMID: 20499174 DOI: 10.1007/s10620-010-1281-7] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 2.1] [Reference Citation Analysis]
216 Kurek A, Pawlicki J, Lekstan A, Sekta S, Ziaja J, Cierpka L, Król R. Influence of Experience Acquired by a Liver Transplantation Center on Extension of Donor Acceptance Criteria. Transplantation Proceedings 2018;50:1992-6. [DOI: 10.1016/j.transproceed.2018.02.154] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
217 Schiesser M, Wittert A, Nieuwenhuijs VB, Morphett A, Padbury RT, Barritt GJ. Intermittent ischemia but not ischemic preconditioning is effective in restoring bile flow after ischemia reperfusion injury in the livers of aged rats. J Surg Res 2009;152:61-8. [PMID: 18468629 DOI: 10.1016/j.jss.2008.01.007] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
218 Lang H, Sotiropoulos GC, Kaiser GM, Molmenti EP, Malagó M, Broelsch CE. The role of liver transplantation in the treatment of hilar cholangiocarcinoma. HPB (Oxford) 2005;7:268-72. [PMID: 18333205 DOI: 10.1080/13651820500372780] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
219 Mehrabi A, Fonouni H, Ahmadi R, Schmied BM, Müller SA, Welsch T, Hallscheidt P, Zeier M, Weitz J, Schmidt J. Transplantation of a severely lacerated liver - a case report with review of the literature. Clinical Transplantation 2009;23:321-8. [DOI: 10.1111/j.1399-0012.2008.00914.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
220 Eris C, Akbulut S, Sakcak I, Kayaalp C, Ara C, Yilmaz S. Liver Transplant With a Marginal Donor Graft Containing a Hydatid Cyst—A Case Report. Transplantation Proceedings 2013;45:828-30. [DOI: 10.1016/j.transproceed.2012.11.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
221 Pareja E, Cortes M, Hervás D, Mir J, Valdivieso A, Castell JV, Lahoz A. A score model for the continuous grading of early allograft dysfunction severity. Liver Transpl. 2015;21:38-46. [PMID: 25204890 DOI: 10.1002/lt.23990] [Cited by in Crossref: 69] [Cited by in F6Publishing: 58] [Article Influence: 8.6] [Reference Citation Analysis]
222 He S, Rehman H, Shi Y, Krishnasamy Y, Lemasters JJ, Schnellmann RG, Zhong Z. Suramin decreases injury and improves regeneration of ethanol-induced steatotic partial liver grafts. J Pharmacol Exp Ther. 2013;344:417-425. [PMID: 23161217 DOI: 10.1124/jpet.112.199919] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
223 Kim SH, Park GC, Hwang S, Ahn CS, Kim KH, Moon DB, Ha TY, Song GW, Jung DH, Cho HD, Kwon JH, Jung YK, Ha SM, Kang SH, Lee SG. Results of Adult Living Donor Liver Transplantation with Sixth-Decade Donors: A Propensity Score Matching Study in a High-Volume Institution. Ann Transplant 2018;23:802-7. [PMID: 30442881 DOI: 10.12659/AOT.911550] [Cited by in Crossref: 3] [Article Influence: 0.8] [Reference Citation Analysis]
224 Grazi G, Ravaioli M, Zanello M, Ercolani G, Cescon M, Varotti G, Del Gaudio M, Vetrone G, Lauro A, Ramacciato G, Pinna A. Using Elderly Donors in Liver Transplantation. Transplantation Proceedings 2005;37:2582-3. [DOI: 10.1016/j.transproceed.2005.06.056] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
225 Hoyer DP, Paul A, Minor T. Prediction of Hepatocellular Preservation Injury Immediately Before Human Liver Transplantation by Controlled Oxygenated Rewarming. Transplant Direct 2017;3:e122. [PMID: 28349122 DOI: 10.1097/TXD.0000000000000636] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
226 Duarte S, Kato H, Kuriyama N, Suko K, Ishikawa TO, Busuttil RW, Herschman HR, Coito AJ. Hepatic ischemia and reperfusion injury in the absence of myeloid cell-derived COX-2 in mice. PLoS One 2014;9:e96913. [PMID: 24819536 DOI: 10.1371/journal.pone.0096913] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
227 Demetris AJ, Fontes P, Lunz JG, Specht S, Murase N, Marcos A. Wound healing in the biliary tree of liver allografts. Cell Transplant. 2006;15 Suppl 1:S57-S65. [PMID: 16826796 DOI: 10.3727/000000006783982386] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 1.8] [Reference Citation Analysis]
228 Stoll P, Schwer CI, Goebel U, Buerkle H, Hoetzel A, Schmidt R. Hepatic steatosis prevents heme oxygenase-1 induction by isoflurane in the rat liver. World J Gastroenterol 2011; 17(37): 4184-4190 [PMID: 22072849 DOI: 10.3748/wjg.v17.i37.4184] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
229 Kotloff RM, Blosser S, Fulda GJ, Malinoski D, Ahya VN, Angel L, Byrnes MC, DeVita MA, Grissom TE, Halpern SD. Management of the Potential Organ Donor in the ICU: Society of Critical Care Medicine/American College of Chest Physicians/Association of Organ Procurement Organizations Consensus Statement. Crit Care Med. 2015;43:1291-1325. [PMID: 25978154 DOI: 10.1097/ccm.0000000000000958] [Cited by in Crossref: 171] [Cited by in F6Publishing: 50] [Article Influence: 24.4] [Reference Citation Analysis]
230 Jiménez-Romero C, Caso Maestro O, Cambra Molero F, Justo Alonso I, Alegre Torrado C, Manrique Municio A, Calvo Pulido J, Loinaz Segurola C, Moreno González E. Using old liver grafts for liver transplantation: Where are the limits? World J Gastroenterol 2014; 20(31): 10691-10702 [PMID: 25152573 DOI: 10.3748/wjg.v20.i31.10691] [Cited by in CrossRef: 57] [Cited by in F6Publishing: 49] [Article Influence: 7.1] [Reference Citation Analysis]
231 Demetris AJ, III JGL, Specht S, Nozaki I. Biliary wound healing, ductular reactions, and IL-6/gp130 signaling in the development of liver disease. World J Gastroenterol 2006; 12(22): 3512-3522 [PMID: 16773708 DOI: 10.3748/wjg.v12.i22.3512] [Cited by in CrossRef: 34] [Cited by in F6Publishing: 36] [Article Influence: 2.1] [Reference Citation Analysis]
232 Martins AMA, Coelho GR, Marques GA, Moraes MO, Valença Jr. JT, Garcia JHP. HEPATIC STEATOSIS ASSESSMENT:. Arq Gastroenterol 2013;50:15-8. [DOI: 10.1590/s0004-28032013000100004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
233 Uto K, Sakamoto S, Que W, Shimata K, Hashimoto S, Sakisaka M, Narita Y, Yoshii D, Zhong L, Komohara Y, Li XK, Inomata Y, Hibi T. Hydrogen-rich solution attenuates cold ischemia-reperfusion injury in rat liver transplantation. BMC Gastroenterol 2019;19:25. [PMID: 30736744 DOI: 10.1186/s12876-019-0939-7] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
234 Collin de l'Hortet A, Takeishi K, Guzman-Lepe J, Handa K, Matsubara K, Fukumitsu K, Dorko K, Presnell SC, Yagi H, Soto-Gutierrez A. Liver-Regenerative Transplantation: Regrow and Reset. Am J Transplant 2016;16:1688-96. [PMID: 26699680 DOI: 10.1111/ajt.13678] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 4.7] [Reference Citation Analysis]
235 Oshima K, Yabata Y, Yoshinari D, Takeyoshi I. The effects of cyclooxygenase (COX)-2 inhibition on ischemia-reperfusion injury in liver transplantation. J Invest Surg 2009;22:239-45. [PMID: 19842898 DOI: 10.1080/08941930903040080] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
236 Liu Z, Jia J, Ning H, Que S, Zhou L, Zheng S. Systematic Evaluation of the Safety Threshold for Allograft Macrovesicular Steatosis in Cadaveric Liver Transplantation. Front Physiol 2019;10:429. [PMID: 31105577 DOI: 10.3389/fphys.2019.00429] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
237 Briceño J, Ciria R, de la Mata M. Donor-recipient matching: Myths and realities. Journal of Hepatology 2013;58:811-20. [DOI: 10.1016/j.jhep.2012.10.020] [Cited by in Crossref: 41] [Cited by in F6Publishing: 32] [Article Influence: 4.6] [Reference Citation Analysis]
238 Jun MJ, Shim JH, Kim SY, Seo N, Kim KM, Lim YS, Lee HC, Yu E, Lee SG. Clinical implications of preoperative and intraoperative liver biopsies for evaluating donor steatosis in living related liver transplantation. Liver Transpl. 2014;20:437-445. [PMID: 24478019 DOI: 10.1002/lt.23832] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
239 Gajate Martín L, Martín Grande A, Parise Roux D, González Cibrián C, Fernández Martín C, Rodríguez Gandía M, López Buenadicha A. Short-term Results of Liver Transplantation With Octogenarian Donors. Transplantation Proceedings 2018;50:184-91. [DOI: 10.1016/j.transproceed.2017.12.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
240 Puhl G, Olschewski P, Schoning W, Neumann U, Sredznizki D, Dankof A, Settmacher U, Neuhaus P. 24-h storage of pig livers in UW, HTK, hydroxyethyl starch, and saline solution: is microdialysis an appropriate method for the continuous graft monitoring during preservation? Transplant Int 2006;19:303-9. [DOI: 10.1111/j.1432-2277.2006.00289.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
241 Dagher NN. Living Donor Liver Transplantation: A Western Perspective. Int Anesthesiol Clin 2017;55:135-47. [PMID: 28288032 DOI: 10.1097/AIA.0000000000000135] [Reference Citation Analysis]
242 Yamanaka K, Houben P, Bruns H, Schultze D, Hatano E, Schemmer P. A systematic review of pharmacological treatment options used to reduce ischemia reperfusion injury in rat liver transplantation. PLoS One 2014;10:e0122214. [PMID: 25919110 DOI: 10.1371/journal.pone.0122214] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 3.1] [Reference Citation Analysis]
243 Predmore Z, Doby B, Bozzi DG, Durand C, Segev D, Sugarman J, Tobian AAR, Wu AW. Barriers experienced by organ procurement organizations in implementing the HOPE act and HIV-positive organ donation. AIDS Care 2021;:1-7. [PMID: 34180726 DOI: 10.1080/09540121.2021.1945999] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
244 Levesque E, Hoti E, Khalfallah M, Salloum C, Ricca L, Vibert E, Azoulay D. Impact of reversible cardiac arrest in the brain-dead organ donor on the outcome of adult liver transplantation. Liver Transpl 2011;17:1159-66. [DOI: 10.1002/lt.22372] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
245 Kitano Y, Allard MA, Nakada S, Beghdadi N, Karam V, Vibert E, Sa Cunha A, Castaing D, Cherqui D, Baba H, Adam R. Early- and long-term outcomes of liver transplantation with rescue allocation grafts. Clin Transplant 2021;35:e14046. [PMID: 32686220 DOI: 10.1111/ctr.14046] [Reference Citation Analysis]
246 Haugen CE, Holscher CM, Luo X, Bowring MG, Orandi BJ, Thomas AG, Garonzik-Wang J, Massie AB, Philosophe B, McAdams-DeMarco M, Segev DL. Assessment of Trends in Transplantation of Liver Grafts From Older Donors and Outcomes in Recipients of Liver Grafts From Older Donors, 2003-2016. JAMA Surg 2019;154:441-9. [PMID: 30758494 DOI: 10.1001/jamasurg.2018.5568] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
247 Li S, Zheng X, Li H, Zheng J, Chen X, Liu W, Tai Y, Zhang Y, Wang G, Yang Y. Mesenchymal Stem Cells Ameliorate Hepatic Ischemia/Reperfusion Injury via Inhibition of Neutrophil Recruitment. J Immunol Res. 2018;2018:7283703. [PMID: 30622980 DOI: 10.1155/2018/7283703] [Cited by in Crossref: 14] [Cited by in F6Publishing: 18] [Article Influence: 3.5] [Reference Citation Analysis]
248 Pomposelli J, Verbesey J, Simpson M, Lewis W, Gordon F, Khettry U, Wald C, Ata S, Morin D, Garrigan K, Jenkins R, Pomfret E. Improved Survival After Live Donor Adult Liver Transplantation (LDALT) Using Right Lobe Grafts: Program Experience and Lessons Learned: Improved Survival After LDALT Using Right Lobe Grafts. American Journal of Transplantation 2006;6:589-98. [DOI: 10.1111/j.1600-6143.2005.01220.x] [Cited by in Crossref: 53] [Cited by in F6Publishing: 45] [Article Influence: 3.3] [Reference Citation Analysis]
249 Goff C, Zhang T, McDonald M, Anand A, Galvan NTN, Kanwal F, Cholankeril G, Hernaez R, Goss JA, Rana A. Marginal allografts in liver transplantation have a limited impact on length of stay. Clin Transplant 2021;:e14544. [PMID: 34854503 DOI: 10.1111/ctr.14544] [Reference Citation Analysis]
250 Renz JF. A critical analysis of liver allograft utilization from the US deceased donor pool: Editorial. Liver Transpl 2010;16:543-7. [DOI: 10.1002/lt.22040] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
251 Pérez-ortiz M, Cruz-ramírez M, Ayllón-terán M, Heaton N, Ciria R, Hervás-martínez C. An organ allocation system for liver transplantation based on ordinal regression. Applied Soft Computing 2014;14:88-98. [DOI: 10.1016/j.asoc.2013.07.017] [Cited by in Crossref: 26] [Cited by in F6Publishing: 4] [Article Influence: 3.3] [Reference Citation Analysis]
252 Zarrinpar A, Lee C, Noguchi E, Yersiz H, Agopian VG, Kaldas FM, Farmer DG, Busuttil RW. A rapid, reproducible, noninvasive predictor of liver graft survival. J Surg Res. 2015;197:183-190. [PMID: 25940156 DOI: 10.1016/j.jss.2015.03.093] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
253 . III Reunión de consenso de la Sociedad Española de Trasplante Hepático (SETH). Hepatitis C, trasplante hepático de donante vivo, calidad de los injertos hepáticos y calidad de los programas de trasplante hepático. Cirugía Española 2011;89:487-504. [DOI: 10.1016/j.ciresp.2011.06.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
254 Maluf DG, Edwards EB, Kauffman HM. Utilization of extended donor criteria liver allograft: Is the elevated risk of failure independent of the model for end-stage liver disease score of the recipient? Transplantation. 2006;82:1653-1657. [PMID: 17198254 DOI: 10.1097/01.tp.0000250571.41361.21] [Cited by in Crossref: 72] [Cited by in F6Publishing: 61] [Article Influence: 4.8] [Reference Citation Analysis]
255 Jiménez-Castro MB, Cornide-Petronio ME, Gracia-Sancho J, Peralta C. Inflammasome-Mediated Inflammation in Liver Ischemia-Reperfusion Injury. Cells 2019;8:E1131. [PMID: 31547621 DOI: 10.3390/cells8101131] [Cited by in Crossref: 36] [Cited by in F6Publishing: 39] [Article Influence: 12.0] [Reference Citation Analysis]
256 Núñez K, Hamed M, Fort D, Bruce D, Thevenot P, Cohen A. Links between donor macrosteatosis, interleukin-33 and complement after liver transplantation. World J Transplant 2020; 10(5): 117-128 [PMID: 32864357 DOI: 10.5500/wjt.v10.i5.117] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
257 Foley DP, Fernandez LA, Leverson G, Chin LT, Krieger N, Cooper JT, Shames BD, Becker YT, Odorico JS, Knechtle SJ. Donation after cardiac death: the University of Wisconsin experience with liver transplantation. Ann Surg. 2005;242:724-731. [PMID: 16244547 DOI: 10.1097/01.sla.0000186178.07110.92] [Cited by in Crossref: 280] [Cited by in F6Publishing: 241] [Article Influence: 16.5] [Reference Citation Analysis]
258 Muscari F, Guinard JP, Foppa B, Trocard P, Danjoux M, Kamel MS, Duffas JP, Rostaing L, Fourtanier G, Suc B. Biological changes after liver transplantation according to the presence or not of graft steatosis. Transplant Proc 2008;40:3562-5. [PMID: 19100438 DOI: 10.1016/j.transproceed.2008.06.087] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
259 Jiménez-Castro MB, Casillas-Ramírez A, Negrete-Sánchez E, Avalos-de León CG, Gracia-Sancho J, Peralta C. Adipocytokines in Steatotic Liver Surgery/Transplantation. Transplantation 2019;103:71-7. [PMID: 30586349 DOI: 10.1097/TP.0000000000002098] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
260 Stey A, Doucette J, Florman S, Emre S. Donor and Recipient Factors Predicting Time to Graft Failure Following Orthotopic Liver Transplantation: A Transplant Risk Index. Transplantation Proceedings 2013;45:2077-82. [DOI: 10.1016/j.transproceed.2013.06.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
261 Benko T, Gallinat A, Minor T, Saner FH, Sotiropoulos GC, Paul A, Hoyer DP. The postoperative Model for End stage Liver Disease score as a predictor of short-term outcome after transplantation of extended criteria donor livers: . European Journal of Gastroenterology & Hepatology 2017;29:716-22. [DOI: 10.1097/meg.0000000000000851] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
262 Mendes-Braz M, Elias-Miro M, Jimenez-Castro MB, Casillas-Ramirez A, Ramalho FS, Peralta C. The current state of knowledge of hepatic ischemia-reperfusion injury based on its study in experimental models. J biomed biotechnol. 2012;2012:298657. [PMID: 22649277 DOI: 10.1155/2012/298657] [Cited by in Crossref: 86] [Cited by in F6Publishing: 88] [Article Influence: 8.6] [Reference Citation Analysis]
263 Chu MJ, Dare AJ, Phillips AR, Bartlett AS. Donor Hepatic Steatosis and Outcome After Liver Transplantation: a Systematic Review. J Gastrointest Surg. 2015;19:1713-1724. [PMID: 25917535 DOI: 10.1007/s11605-015-2832-1] [Cited by in Crossref: 81] [Cited by in F6Publishing: 80] [Article Influence: 11.6] [Reference Citation Analysis]
264 Saha A, Naidu C, Ramesh G, Chatterjee J, Puri P, Nandi B, Nambiar P, Madan R. Liver transplantation in Indian Armed Forces-initial experience. Med J Armed Forces India 2012;68:110-7. [PMID: 24669047 DOI: 10.1016/S0377-1237(12)60018-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
265 Xie H, Zhang L, Guo D, Yang Z, Zhu H, Zhou K, Feng X, Wei Q, Xu X, Song P, Wen X, Li J, Liu J, Zheng S. Protein Profiles of Pretransplant Grafts Predict Early Allograft Dysfunction After Liver Transplantation From Donation After Circulatory Death. Transplantation 2020;104:79-89. [PMID: 31283675 DOI: 10.1097/TP.0000000000002787] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
266 El-badry AM, Moritz W, Contaldo C, Tian Y, Graf R, Clavien P. Prevention of reperfusion injury and microcirculatory failure in macrosteatotic mouse liver by omega-3 fatty acids. Hepatology 2007;45:855-63. [DOI: 10.1002/hep.21625] [Cited by in Crossref: 82] [Cited by in F6Publishing: 77] [Article Influence: 5.5] [Reference Citation Analysis]
267 Kanoria S, Jalan R, Davies NA, Seifalian AM, Williams R, Davidson BR. Remote ischaemic preconditioning of the hind limb reduces experimental liver warm ischaemia-reperfusion injury. Br J Surg. 2006;93:762-768. [PMID: 16609953 DOI: 10.1002/bjs.5331] [Cited by in Crossref: 76] [Cited by in F6Publishing: 79] [Article Influence: 4.8] [Reference Citation Analysis]
268 Ayllón MD, Ciria R, Cruz-ramírez M, Pérez-ortiz M, Gómez I, Valente R, O'grady J, de la Mata M, Hervás-martínez C, Heaton ND, Briceño J. Validation of artificial neural networks as a methodology for donor-recipient matching for liver transplantation: Ayllón et al. Liver Transpl 2018;24:192-203. [DOI: 10.1002/lt.24870] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
269 Hu C, Zhao L, Zhang F, Li L. Melatonin and its protective role in attenuating warm or cold hepatic ischaemia/reperfusion injury. Cell Prolif 2021;54:e13021. [PMID: 33751704 DOI: 10.1111/cpr.13021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
270 Dubbeld J, Hoekstra H, Farid W, Ringers J, Porte RJ, Metselaar HJ, Baranski AG, Kazemier G, van den Berg AP, van Hoek B. Similar liver transplantation survival with selected cardiac death donors and brain death donors. Br J Surg. 2010;97:744-753. [PMID: 20393979 DOI: 10.1002/bjs.7043] [Cited by in Crossref: 145] [Cited by in F6Publishing: 130] [Article Influence: 12.1] [Reference Citation Analysis]
271 Jiménez-romero C, Clemares-lama M, Manrique-municio A, García-sesma A, Calvo-pulido J, Moreno-gonzález E. Long-Term Results Using Old Liver Grafts for Transplantation: Sexagenerian Versus Liver Donors Older than 70 Years. World J Surg 2013;37:2211-21. [DOI: 10.1007/s00268-013-2085-7] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 3.6] [Reference Citation Analysis]
272 Yang F, Shang L, Wang S, Liu Y, Ren H, Zhu W, Shi X. TNFα-Mediated Necroptosis Aggravates Ischemia-Reperfusion Injury in the Fatty Liver by Regulating the Inflammatory Response. Oxid Med Cell Longev 2019;2019:2301903. [PMID: 31214277 DOI: 10.1155/2019/2301903] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 4.7] [Reference Citation Analysis]
273 Garcia JH, Coelho GR, Marques GA, Gadelha JB, Vasconcelos JB, Valença Jr. JT, Esmeraldo RM, Meija JA, Leite CA, Almeida ER. Successful Organ Transplantation from Donors Poisoned with a Carbamate Insecticide: Organ Transplantation from Donors Poisoned with Carbamate. American Journal of Transplantation 2010;10:1490-2. [DOI: 10.1111/j.1600-6143.2010.03132.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
274 Turgeon NA, Sollinger HW, Fernandez LA, Musat AI, Chin LT, Kalayoglu M, Knechtle SJ, D’alessandro AM. Hepatic steatosis and liver transplantation: . Current Opinion in Organ Transplantation 2004;9:123-9. [DOI: 10.1097/01.mot.0000127681.70265.bc] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
275 Banan B, Watson R, Xu M, Lin Y, Chapman W. Development of a normothermic extracorporeal liver perfusion system toward improving viability and function of human extended criteria donor livers. Liver Transpl. 2016;22:979-993. [PMID: 27027254 DOI: 10.1002/lt.24451] [Cited by in Crossref: 48] [Cited by in F6Publishing: 46] [Article Influence: 9.6] [Reference Citation Analysis]
276 Feng S, Roberts J. An Older Liver in the Hand, or a (Possibly) Younger Liver in the Bush? American Journal of Transplantation 2005;5:425-7. [DOI: 10.1111/j.1600-6143.2005.00787.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
277 Dunn W, O’Neil M, Zhao J, Wu CH, Roberts B, Chakraborty S, Sherman C, Weaver B, Taylor R, Olson J. Donor PNPLA3 rs738409 genotype affects fibrosis progression in liver transplantation for hepatitis C. Hepatology. 2014;59:453-460. [PMID: 24123231 DOI: 10.1002/hep.26758] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
278 Ben Mosbah I, Mouchel Y, Pajaud J, Ribault C, Lucas C, Laurent A, Boudjema K, Morel F, Corlu A, Compagnon P. Pretreatment with mangafodipir improves liver graft tolerance to ischemia/reperfusion injury in rat. PLoS One. 2012;7:e50235. [PMID: 23226251 DOI: 10.1371/journal.pone.0050235] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 2.9] [Reference Citation Analysis]
279 Gastaca M. Extended Criteria Donors in Liver Transplantation: Adapting Donor Quality and Recipient. Transplantation Proceedings 2009;41:975-9. [DOI: 10.1016/j.transproceed.2009.02.016] [Cited by in Crossref: 46] [Cited by in F6Publishing: 33] [Article Influence: 3.5] [Reference Citation Analysis]
280 Hoyer DP, Mathé Z, Gallinat A, Canbay AC, Treckmann JW, Rauen U, Paul A, Minor T. Controlled Oxygenated Rewarming of Cold Stored Livers Prior to Transplantation: First Clinical Application of a New Concept. Transplantation 2016;100:147-52. [PMID: 26479280 DOI: 10.1097/TP.0000000000000915] [Cited by in Crossref: 78] [Cited by in F6Publishing: 33] [Article Influence: 13.0] [Reference Citation Analysis]
281 Cassuto JR, Patel SA, Tsoulfas G, Orloff MS, Abt PL. The cumulative effects of cold ischemic time and older donor age on liver graft survival. J Surg Res. 2008;148:38-44. [PMID: 18570929 DOI: 10.1016/j.jss.2008.03.018] [Cited by in Crossref: 39] [Cited by in F6Publishing: 26] [Article Influence: 2.8] [Reference Citation Analysis]
282 Nakamuta M, Morizono S, Soejima Y, Yoshizumi T, Aishima S, Takasugi S, Yoshimitsu K, Enjoji M, Kotoh K, Taketomi A, Uchiyama H, Shimada M, Nawata H, Maehara Y. Short-term intensive treatment for donors with hepatic steatosis in living-donor liver transplantation. Transplantation. 2005;80:608-612. [PMID: 16177634 DOI: 10.1097/01.tp.0000166009.77444.f3] [Cited by in Crossref: 81] [Cited by in F6Publishing: 77] [Article Influence: 4.8] [Reference Citation Analysis]
283 Padrissa-Altés S, Zaouali MA, Bartrons R, Roselló-Catafau J. Ubiquitin-proteasome system inhibitors and AMPK regulation in hepatic cold ischaemia and reperfusion injury: possible mechanisms. Clin Sci (Lond). 2012;123:93-98. [PMID: 22455352 DOI: 10.1042/cs20110093] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
284 Abecassis M, Bridges ND, Clancy CJ, Dew MA, Eldadah B, Englesbe MJ, Flessner MF, Frank JC, Friedewald J, Gill J, Gries C, Halter JB, Hartmann EL, Hazzard WR, Horne FM, Hosenpud J, Jacobson P, Kasiske BL, Lake J, Loomba R, Malani PN, Moore TM, Murray A, Nguyen MH, Powe NR, Reese PP, Reynolds H, Samaniego MD, Schmader KE, Segev DL, Shah AS, Singer LG, Sosa JA, Stewart ZA, Tan JC, Williams WW, Zaas DW, High KP. Solid-organ transplantation in older adults: current status and future research. Am J Transplant 2012;12:2608-22. [PMID: 22958872 DOI: 10.1111/j.1600-6143.2012.04245.x] [Cited by in Crossref: 87] [Cited by in F6Publishing: 77] [Article Influence: 8.7] [Reference Citation Analysis]
285 Koneru B, Fisher A, He Y, Klein KM, Skurnick J, Wilson DJ, de la Torre AN, Merchant A, Arora R, Samanta AK. Ischemic preconditioning in deceased donor liver transplantation: a prospective randomized clinical trial of safety and efficacy. Liver Transpl. 2005;11:196-202. [PMID: 15666380 DOI: 10.1002/lt.20315] [Cited by in Crossref: 99] [Cited by in F6Publishing: 93] [Article Influence: 5.8] [Reference Citation Analysis]
286 Li H, Lu J, Zhou X, Pan D, Guo D, Ling H, Yang H, He Y, Chen G. Quantitative Analysis of Hepatic Microcirculation in Rabbits After Liver Ischemia-Reperfusion Injury Using Contrast-Enhanced Ultrasound. Ultrasound Med Biol 2017;43:2469-76. [PMID: 28684184 DOI: 10.1016/j.ultrasmedbio.2017.06.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
287 Reeder SB, Cruite I, Hamilton G, Sirlin CB. Quantitative Assessment of Liver Fat with Magnetic Resonance Imaging and Spectroscopy. J Magn Reson Imaging 2011;34:729-49. [PMID: 22025886 DOI: 10.1002/jmri.22775] [Cited by in Crossref: 434] [Cited by in F6Publishing: 198] [Article Influence: 39.5] [Reference Citation Analysis]
288 Foster R, Zimmerman M, Trotter JF. Expanding Donor Options: Marginal, Living, and Split Donors. Clinics in Liver Disease 2007;11:417-29. [DOI: 10.1016/j.cld.2007.04.004] [Cited by in Crossref: 45] [Cited by in F6Publishing: 42] [Article Influence: 3.0] [Reference Citation Analysis]
289 Nieuwenhuijs VB, De Bruijn MT, Padbury RT, Barritt GJ. Hepatic ischemia-reperfusion injury: roles of Ca2+ and other intracellular mediators of impaired bile flow and hepatocyte damage. Dig Dis Sci. 2006;51:1087-1102. [PMID: 16865576 DOI: 10.1007/s10620-006-8014-y] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 2.6] [Reference Citation Analysis]
290 Routh D, Naidu S, Sharma S, Ranjan P, Godara R. Changing pattern of donor selection criteria in deceased donor liver transplant: a review of literature. J Clin Exp Hepatol. 2013;3:337-346. [PMID: 25755521 DOI: 10.1016/j.jceh.2013.11.007] [Cited by in Crossref: 30] [Cited by in F6Publishing: 23] [Article Influence: 3.3] [Reference Citation Analysis]
291 Hussein MH, Hashimoto T, Daoud GA, Kakita H, Kato S, Goto T, Hibi M, Kato T, Okumura N, Tomishige H, Hara F, Ito T, Fukuda S, Kato I, Suzuki T, Suzuki S, Togari H. Oxidative stress after living related liver transplantation subsides with time in pediatric patients. Pediatr Surg Int 2011;27:17-22. [PMID: 20872007 DOI: 10.1007/s00383-010-2721-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
292 Boncompagni E, Gini E, Ferrigno A, Milanesi G, Gringeri E, Barni S, Cillo U, Vairetti M, Freitas I. Decreased apoptosis in fatty livers submitted to subnormothermic machine-perfusion respect to cold storage. Eur J Histochem. 2011;55:e40. [PMID: 22297446 DOI: 10.4081/ejh.2011.e40] [Cited by in Crossref: 13] [Cited by in F6Publishing: 21] [Article Influence: 1.2] [Reference Citation Analysis]
293 Darius T, Monbaliu D, Jochmans I, Meurisse N, Desschans B, Coosemans W, Komuta M, Roskams T, Cassiman D, van der Merwe S, Van Steenbergen W, Verslype C, Laleman W, Aerts R, Nevens F, Pirenne J. Septuagenarian and octogenarian donors provide excellent liver grafts for transplantation. Transplant Proc. 2012;44:2861-2867. [PMID: 23146543 DOI: 10.1016/j.transproceed.2012.09.076] [Cited by in Crossref: 42] [Cited by in F6Publishing: 37] [Article Influence: 4.7] [Reference Citation Analysis]
294 Gao B. Therapeutic potential of interleukin-6 in preventing obesity- and alcohol-associated fatty liver transplant failure. Alcohol. 2004;34:59-65. [PMID: 15670667 DOI: 10.1016/j.alcohol.2004.07.006] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 1.5] [Reference Citation Analysis]
295 Bertuzzo VR, Giannella M, Cucchetti A, Pinna AD, Grossi A, Ravaioli M, Del Gaudio M, Cristini F, Viale P, Cescon M. Impact of preoperative infection on outcome after liver transplantation. Br J Surg. 2017;104:e172-e181. [PMID: 28121031 DOI: 10.1002/bjs.10449] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
296 Navarra T, Simone PD, Turco SD, Filipponi F, Basta G. Involvement of the receptor for advanced glycation end products in liver transplantation. Annals of Hepatology 2015;14:190-7. [DOI: 10.1016/s1665-2681(19)30781-1] [Cited by in Crossref: 5] [Article Influence: 0.7] [Reference Citation Analysis]
297 Ciesek S, Manns M, Strassburg C. [Sequelae of organ transplantation]. Internist (Berl) 2006;47:252, 254-6, 258-60 passim. [PMID: 16470354 DOI: 10.1007/s00108-006-1583-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
298 Ramsey HE, Da Silva CG, Longo CR, Csizmadia E, Studer P, Patel VI, Damrauer SM, Siracuse JJ, Daniel S, Ferran C. A20 protects mice from lethal liver ischemia/reperfusion injury by increasing peroxisome proliferator-activated receptor-alpha expression. Liver Transpl. 2009;15:1613-1621. [PMID: 19877201 DOI: 10.1002/lt.21879] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 2.9] [Reference Citation Analysis]
299 Busuttil RW, Lipshutz GS, Kupiec-Weglinski JW, Ponthieux S, Gjertson DW, Cheadle C, Watkins T, Ehrlich E, Katz E, Squiers EC, Rabb H, Hemmerich S. rPSGL-Ig for improvement of early liver allograft function: a double-blind, placebo-controlled, single-center phase II study. Am J Transplant. 2011;11:786-797. [PMID: 21401865 DOI: 10.1111/j.1600-6143.2011.03441.x] [Cited by in Crossref: 45] [Cited by in F6Publishing: 38] [Article Influence: 4.1] [Reference Citation Analysis]
300 McCormack L, Quiñonez E, Ríos MM, Capitanich P, Goldaracena N, Cabo JK, Anders M, Osatnik J, Comignani P, Mezzadri N, Mastai RC. Rescue policy for discarded liver grafts: a single-centre experience of transplanting livers 'that nobody wants'. HPB (Oxford) 2010;12:523-30. [PMID: 20887319 DOI: 10.1111/j.1477-2574.2010.00193.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
301 Chu MJ, Hickey AJ, Jiang Y, Petzer A, Bartlett AS, Phillips AR. Mitochondrial dysfunction in steatotic rat livers occurs because a defect in complex i makes the liver susceptible to prolonged cold ischemia. Liver Transpl 2015;21:396-407. [PMID: 25312517 DOI: 10.1002/lt.24024] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
302 Brandl A, Stolzlechner P, Eschertzhuber S, Aigner F, Weiss S, Vogel W, Krannich A, Neururer S, Pratschke J, Graziadei I. Inferior graft survival of hepatitis B core positive grafts is not influenced by post-transplant hepatitis B infection in liver recipients-5-year single-center experience. Transpl Int. 2016;29:471-482. [PMID: 26716608 DOI: 10.1111/tri.12741] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
303 Garonzik-wang JM, James NT, Arendonk KJV, Gupta N, Orandi BJ, Hall EC, Massie AB, Montgomery RA, Dagher NN, Singer AL, Cameron AM, Segev DL. The Aggressive Phenotype Revisited: Utilization of Higher-Risk Liver Allografts: Liver Aggressive-Center Phenotype. American Journal of Transplantation 2013;13:936-42. [DOI: 10.1111/ajt.12151] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 3.8] [Reference Citation Analysis]
304 Lo IJ, Lefkowitch JH, Feirt N, Alkofer B, Kin C, Samstein B, Guarrera JV, Renz JF. Utility of liver allograft biopsy obtained at procurement. Liver Transpl 2008;14:639-46. [PMID: 18324657 DOI: 10.1002/lt.21419] [Cited by in Crossref: 37] [Cited by in F6Publishing: 27] [Article Influence: 2.6] [Reference Citation Analysis]
305 Casillas-Ramírez A, Mosbah IB, Ramalho F, Roselló-Catafau J, Peralta C. Past and future approaches to ischemia-reperfusion lesion associated with liver transplantation. Life Sci. 2006;79:1881-1894. [PMID: 16828807 DOI: 10.1016/j.lfs.2006.06.024] [Cited by in Crossref: 132] [Cited by in F6Publishing: 130] [Article Influence: 8.3] [Reference Citation Analysis]
306 Hoti E, Levesque E, Sebagh M, Heneghan HM, Khalfallah M, Castaing D, Azoulay D. Liver Transplantation With Grafts From Donors Who Die From Suicide by Hanging: A Matched Cohort Study. Transplantation 2014;98:1236-43. [DOI: 10.1097/tp.0000000000000201] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
307 Morioka D, Egawa H, Kasahara M, Ito T, Haga H, Takada Y, Shimada H, Tanaka K. Outcomes of adult-to-adult living donor liver transplantation: a single institution’s experience with 335 consecutive cases. Ann Surg. 2007;245:315-325. [PMID: 17245187 DOI: 10.1097/01.sla.0000236600.24667.a4] [Cited by in Crossref: 140] [Cited by in F6Publishing: 130] [Article Influence: 9.3] [Reference Citation Analysis]
308 Ravaioli M, Grazi GL, Ercolani G, Cescon M, Del Gaudio M, Zanello M, Ballardini G, Varotti G, Vetrone G, Tuci F. Liver allocation for hepatocellular carcinoma: a European Center policy in the pre-MELD era. Transplantation. 2006;81:525-530. [PMID: 16495798 DOI: 10.1097/01.tp.0000198741.39637.44] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
309 Kuriyama N, Duarte S, Hamada T, Busuttil RW, Coito AJ. Tenascin-C: a novel mediator of hepatic ischemia and reperfusion injury. Hepatology. 2011;54:2125-2136. [PMID: 21898491 DOI: 10.1002/hep.24639] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 3.6] [Reference Citation Analysis]
310 Lau L, Kankanige Y, Rubinstein B, Jones R, Christophi C, Muralidharan V, Bailey J. Machine-Learning Algorithms Predict Graft Failure After Liver Transplantation. Transplantation 2017;101:e125-32. [PMID: 27941428 DOI: 10.1097/TP.0000000000001600] [Cited by in Crossref: 47] [Cited by in F6Publishing: 19] [Article Influence: 9.4] [Reference Citation Analysis]
311 Reeder SB, Sirlin CB. Quantification of liver fat with magnetic resonance imaging. Magn Reson Imaging Clin N Am. 2010;18:337-357, ix. [PMID: 21094444 DOI: 10.1016/j.mric.2010.08.013] [Cited by in Crossref: 172] [Cited by in F6Publishing: 157] [Article Influence: 15.6] [Reference Citation Analysis]
312 Alwayn IP, Porte RJ. How to make steatotic livers suitable for transplantation. Liver Transpl 2007;13:480-2. [DOI: 10.1002/lt.21026] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
313 Ghinolfi D, Rreka E, Pezzati D, Filipponi F, De Simone P. Perfusion machines and hepatocellular carcinoma: a good match between a marginal organ and an advanced disease? Transl Gastroenterol Hepatol 2017;2:87. [PMID: 29264425 DOI: 10.21037/tgh.2017.10.01] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
314 Tomescu D, Popescu M, Jipa L, Fota R, Ungureanu D, Zamfir R, Orban C, Dima SO, Popescu I. The impact of donor liver graft quality on postoperative outcome in liver transplant recipients. A single centre experience. Rom J Anaesth Intensive Care 2016;23:19-26. [PMID: 28913473 DOI: 10.21454/rjaic.7518.231.gft] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
315 Al-Azzawi Y, Stein LL, Shrestha R, Bhasin D, Citron SJ, Rubin RA. Donor-Derived Hepatic Neuroendocrine Tumor: Pause Before Proceeding With Liver Retransplantation. Transplant Direct. 2016;2:e88. [PMID: 27830182 DOI: 10.1097/txd.0000000000000549] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
316 Brown RS, Rush SH, Rosen HR, Langnas AN, Klintmalm GB, Hanto DW, Punch JD. Liver and intestine transplantation: Liver and intestine. American Journal of Transplantation 2004;4:81-92. [DOI: 10.1111/j.1600-6135.2004.00400.x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 36] [Article Influence: 2.3] [Reference Citation Analysis]
317 Hu Z, Mei S, Xiang J, Zhou J, Li Z, Zhou L, Yan S, Wang W, Zheng S. Survival rates after liver transplantation using hypertensive donor grafts: an analysis of the Scientific Registry of Transplant Recipients database. J Hepatobiliary Pancreat Sci 2017;24:441-8. [PMID: 28544515 DOI: 10.1002/jhbp.466] [Reference Citation Analysis]
318 Spetzler VN, Goldaracena N, Kaths JM, Marquez M, Selzner N, Cattral MS, Greig PD, Lilly L, Mcgilvray ID, Levy GA, Ghanekar A, Renner EL, Grant DR, Selzner M. High preoperative bilirubin values protect against reperfusion injury after live donor liver transplantation. Transpl Int 2015;28:1317-25. [DOI: 10.1111/tri.12634] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
319 Tchilikidi KY. Liver graft preservation methods during cold ischemia phase and normothermic machine perfusion. World J Gastrointest Surg 2019; 11(3): 126-142 [PMID: 31057698 DOI: 10.4240/wjgs.v11.i3.126] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
320 Handa K, Matsubara K, Fukumitsu K, Guzman-Lepe J, Watson A, Soto-Gutierrez A. Assembly of human organs from stem cells to study liver disease. Am J Pathol 2014;184:348-57. [PMID: 24333262 DOI: 10.1016/j.ajpath.2013.11.003] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
321 Bertone V, Tarantola E, Ferrigno A, Gringeri E, Barni S, Vairetti M, Freitas I. Altered alkaline phosphatase activity in obese Zucker rats liver respect to lean Zucker and Wistar rats discussed in terms of all putative roles ascribed to the enzyme. Eur J Histochem 2011;55:e5. [PMID: 21556120 DOI: 10.4081/ejh.2011.e5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
322 Hoyer DP, Minor T. Graft Reconditioning before Liver Transplantation. Visc Med 2016;32:250-6. [PMID: 27722161 DOI: 10.1159/000446378] [Reference Citation Analysis]
323 Zheng J, Xiang J, Zhou J, Li Z, Hu Z, Lo CM, Wang W. Liver grafts for transplantation from donors with diabetes: an analysis of the Scientific Registry of Transplant Recipients database. PLoS One 2014;9:e98104. [PMID: 24847864 DOI: 10.1371/journal.pone.0098104] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
324 Wadström J, Ericzon BG, Halloran PF, Bechstein WO, Opelz G, Serón D, Grinyó J, Loupy A, Kuypers D, Mariat C, Clancy M, Jardine AG, Guirado L, Fellström B, O'Grady J, Pirenne J, O'Leary JG, Aluvihare V, Trunečka P, Baccarani U, Neuberger J, Soto-Gutierrez A, Geissler EK, Metzger M, Gray M. Advancing Transplantation: New Questions, New Possibilities in Kidney and Liver Transplantation. Transplantation 2017;101 Suppl 2S:S1-S41. [PMID: 28125449 DOI: 10.1097/TP.0000000000001563] [Cited by in Crossref: 15] [Cited by in F6Publishing: 4] [Article Influence: 3.8] [Reference Citation Analysis]
325 Hisada M, Ota Y, Zhang X, Cameron AM, Gao B, Montgomery RA, Williams GM, Sun Z. Successful transplantation of reduced-sized rat alcoholic fatty livers made possible by mobilization of host stem cells. Am J Transplant 2012;12:3246-56. [PMID: 22994609 DOI: 10.1111/j.1600-6143.2012.04265.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
326 Pratschke J, Mittler J, Neuhaus P. Ausweitung des Spenderpools unter Verwendung marginaler Organe. Chirurg 2008;79:130-4. [DOI: 10.1007/s00104-007-1458-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
327 Nijkamp DM, Slooff MJ, van der Hilst CS, Ijtsma AJ, de Jong KP, Peeters PM, Porte RJ. Surgical injuries of postmortem donor livers: Incidence and impact on outcome after adult liver transplantation. Liver Transpl 2006;12:1365-70. [DOI: 10.1002/lt.20809] [Cited by in Crossref: 31] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
328 Zaouali MA, Boncompagni E, Reiter RJ, Bejaoui M, Freitas I, Pantazi E, Folch-Puy E, Abdennebi HB, Garcia-Gil FA, Roselló-Catafau J. AMPK involvement in endoplasmic reticulum stress and autophagy modulation after fatty liver graft preservation: a role for melatonin and trimetazidine cocktail. J Pineal Res. 2013;55:65-78. [PMID: 23551302 DOI: 10.1111/jpi.12051] [Cited by in Crossref: 67] [Cited by in F6Publishing: 67] [Article Influence: 7.4] [Reference Citation Analysis]
329 Wang Q, Ye F, Ma P, Chen F, Che Y, Zhao X, Yang L. Quantitative magnetic resonance imaging evaluation of hepatic fat content with iron deposition: will it be disturbed? J Int Med Res 2019;47:1958-74. [PMID: 30859893 DOI: 10.1177/0300060519836033] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
330 Park H, Choi HJ, Woo Y, Ahn J, Hong TH, You YK. A Single Center Experience of the Prognosis After Liver Transplantation From Discarded Graft Due to Poor Graft Conditions in Prioritized Centers. Transplantation Proceedings 2022. [DOI: 10.1016/j.transproceed.2021.10.024] [Reference Citation Analysis]
331 Iwamoto T, Yagi T, Umeda Y, Sato D, Matsukawa H, Matsuda H, Shinoura S, Sadamori H, Mizuno K, Yoshida R. The impact of donor age on the outcome of adult living donor liver transplantation. Transplantation. 2008;85:1240-1245. [PMID: 18475178 DOI: 10.1097/tp.0b013e31816c7e90] [Cited by in Crossref: 30] [Cited by in F6Publishing: 5] [Article Influence: 2.1] [Reference Citation Analysis]
332 Halldorson JB, Bakthavatsalam R, Fix O, Reyes JD, Perkins JD. D-MELD, a Simple Predictor of Post Liver Transplant Mortality for Optimization of Donor/Recipient Matching. American Journal of Transplantation 2009;9:318-26. [DOI: 10.1111/j.1600-6143.2008.02491.x] [Cited by in Crossref: 192] [Cited by in F6Publishing: 171] [Article Influence: 14.8] [Reference Citation Analysis]
333 Mangus RS, Fridell JA, Vianna RM, Milgrom ML, Chestovich P, Vandenboom C, Tector AJ. Severe Hypernatremia in Deceased Liver Donors Does Not Impact Early Transplant Outcome. Transplantation 2010;90:438-43. [DOI: 10.1097/tp.0b013e3181e764c0] [Cited by in Crossref: 39] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
334 Fondevila C, Shen XD, Tsuchihashi S, Uchida Y, Freitas MC, Ke B, Busuttil RW, Kupiec-Weglinski JW. The membrane attack complex (C5b-9) in liver cold ischemia and reperfusion injury. Liver Transpl. 2008;14:1133-1141. [PMID: 18668646 DOI: 10.1002/lt.21496] [Cited by in Crossref: 33] [Cited by in F6Publishing: 36] [Article Influence: 2.4] [Reference Citation Analysis]
335 Pretto EA. Perioperative Management of the Recipient of the Extended Criteria Cadaveric Donor Liver (ECDL): A Metabolic Approach. International Anesthesiology Clinics 2006;44:79-96. [DOI: 10.1097/01.aia.0000210816.08158.63] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
336 Hidaka M, Eguchi S, Takatsuki M, Soyama A, Ono S, Adachi T, Natsuda K, Kugiyama T, Hara T, Okada S, Imamura H, Miuma S, Miyaaki H. The Kupffer Cell Number Affects the Outcome of Living Donor Liver Transplantation from Elderly Donors. Transplant Direct 2016;2:e94. [PMID: 27819035 DOI: 10.1097/TXD.0000000000000608] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
337 Chapman WC, Vachharajani N, Collins KM, Garonzik-wang J, Park Y, Wellen JR, Lin Y, Shenoy S, Lowell JA, Doyle MM. Donor Age-Based Analysis of Liver Transplantation Outcomes: Short- and Long-Term Outcomes Are Similar Regardless of Donor Age. Journal of the American College of Surgeons 2015;221:59-69. [DOI: 10.1016/j.jamcollsurg.2015.01.061] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 4.0] [Reference Citation Analysis]
338 Ito T, Nakamura K, Kageyama S, Korayem IM, Hirao H, Kadono K, Aziz J, Younan S, DiNorcia J 3rd, Agopian VG, Yersiz H, Farmer DG, Busuttil RW, Kupiec-Weglinski JW, Kaldas FM. Impact of Rifaximin Therapy on Ischemia/Reperfusion Injury in Liver Transplantation: A Propensity Score-Matched Analysis. Liver Transpl 2019;25:1778-89. [PMID: 31509643 DOI: 10.1002/lt.25633] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
339 Ghinolfi D, De Simone P, Lai Q, Pezzati D, Coletti L, Balzano E, Arenga G, Carrai P, Grande G, Pollina L, Campani D, Biancofiore G, Filipponi F. Risk analysis of ischemic-type biliary lesions after liver transplant using octogenarian donors. Liver Transpl. 2016;22:588-598. [PMID: 26784011 DOI: 10.1002/lt.24401] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 5.6] [Reference Citation Analysis]
340 Zhang Z, Tang Y, Zhao Q, Wang L, Zhu C, Ju W, Wang D, Yang L, Wu L, Chen M, Huang S, Gao N, Zhu Z, Zhang Y, Sun C, Xiong W, Shen Y, Ma Y, Hu A, Zhu X, Rong J, Cai C, Guo Z, He X. Association of Perfusion Characteristics and Posttransplant Liver Function in Ischemia-Free Liver Transplantation.Liver Transpl. 2020;26:1441-1454. [PMID: 32542994 DOI: 10.1002/lt.25825] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
341 Jiménez-Romero C, Cambra F, Caso O, Manrique A, Calvo J, Marcacuzco A, Rioja P, Lora D, Justo I. Octogenarian liver grafts: Is their use for transplant currently justified? World J Gastroenterol 2017; 23(17): 3099-3110 [PMID: 28533667 DOI: 10.3748/wjg.v23.i17.3099] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
342 Mehrabi A, Fonouni H, Müller SA, Schmidt J. Current concepts in transplant surgery: liver transplantation today. Langenbecks Arch Surg. 2008;393:245-260. [PMID: 18309513 DOI: 10.1007/s00423-007-0262-6] [Cited by in Crossref: 52] [Cited by in F6Publishing: 38] [Article Influence: 3.7] [Reference Citation Analysis]
343 Dorado-moreno M, Pérez-ortiz M, Gutiérrez PA, Ciria R, Briceño J, Hervás-martínez C. Dynamically weighted evolutionary ordinal neural network for solving an imbalanced liver transplantation problem. Artificial Intelligence in Medicine 2017;77:1-11. [DOI: 10.1016/j.artmed.2017.02.004] [Cited by in Crossref: 19] [Cited by in F6Publishing: 8] [Article Influence: 3.8] [Reference Citation Analysis]
344 Busuttil RW, Farmer DG, Yersiz H, Hiatt JR, McDiarmid SV, Goldstein LI, Saab S, Han S, Durazo F, Weaver M, Cao C, Chen T, Lipshutz GS, Holt C, Gordon S, Gornbein J, Amersi F, Ghobrial RM. Analysis of long-term outcomes of 3200 liver transplantations over two decades: a single-center experience. Ann Surg. 2005;241:905-16; discussion 916-8. [PMID: 15912040 DOI: 10.1097/01.sla.0000164077.77912.98] [Cited by in Crossref: 301] [Cited by in F6Publishing: 241] [Article Influence: 17.7] [Reference Citation Analysis]
345 He XS, Ma Y, Wu LW, Ju WQ, Wu JL, Hu RD, Chen GH, Huang JF. Safe time to warm ischemia and posttransplant survival of liver graft from non-heart-beating donors. World J Gastroenterol 2004; 10(21): 3157-3160 [PMID: 15457563 DOI: 10.3748/wjg.v10.i21.3157] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
346 Ezekian B, Mulvihill MS, Freischlag K, Yerokun BA, Davis RP, Hartwig MG, Knechtle SJ, Barbas AS. Elevated HbA1c in donor organs from patients without a diagnosis of diabetes portends worse liver allograft survival. Clin Transplant 2017;31. [PMID: 28667782 DOI: 10.1111/ctr.13047] [Reference Citation Analysis]
347 Oliver JB, Peters S, Bongu A, Beidas A, Dikdan G, Brown L, Koneru B. Prerecovery liver biopsy in the brain-dead donor: A case-control study of logistics, safety, precision, and utility: PRERECOVERY LIVER BIOPSY IN THE BRAIN-DEAD DONOR. Liver Transpl 2014;20:237-44. [DOI: 10.1002/lt.23786] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
348 Berthiaume F, Barbe L, Mokuno Y, MacDonald AD, Jindal R, Yarmush ML. Steatosis reversibly increases hepatocyte sensitivity to hypoxia-reoxygenation injury. J Surg Res. 2009;152:54-60. [PMID: 18599084 DOI: 10.1016/j.jss.2007.12.784] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 2.3] [Reference Citation Analysis]
349 Sutherland AI, IJzermans JN, Forsythe JL, Dor FJ. Kidney and liver transplantation in the elderly. Br J Surg. 2016;103:e62-e72. [PMID: 26662845 DOI: 10.1002/bjs.10064] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 3.4] [Reference Citation Analysis]
350 Marcon F, Schlegel A, Bartlett DC, Kalisvaart M, Bishop D, Mergental H, Roberts KJ, Mirza DF, Isaac J, Muiesan P, Perera MT. Utilization of Declined Liver Grafts Yields Comparable Transplant Outcomes and Previous Decline Should Not Be a Deterrent to Graft Use. Transplantation. 2018;102:e211-e218. [PMID: 29702538 DOI: 10.1097/tp.0000000000002127] [Cited by in Crossref: 23] [Cited by in F6Publishing: 7] [Article Influence: 7.7] [Reference Citation Analysis]
351 Chung IS, Kim HY, Shin YH, Ko JS, Gwak MS, Sim WS, Kim GS, Lee SK. Incidence and predictors of post-reperfusion syndrome in living donor liver transplantation. Clin Transplant. 2012;26:539-543. [PMID: 22168355 DOI: 10.1111/j.1399-0012.2011.01568.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 3.0] [Reference Citation Analysis]
352 Ni C, Masters J, Zhu L, Yu W, Jiao Y, Yang Y, Cui C, Yin S, Yang L, Qi B, Ma D. Study design of the DAS-OLT trial: a randomized controlled trial to evaluate the impact of dexmedetomidine on early allograft dysfunction following liver transplantation. Trials 2020;21:582. [PMID: 32591004 DOI: 10.1186/s13063-020-04497-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
353 Duarte S, Shen XD, Fondevila C, Busuttil RW, Coito AJ. Fibronectin-α4β1 interactions in hepatic cold ischemia and reperfusion injury: regulation of MMP-9 and MT1-MMP via the p38 MAPK pathway. Am J Transplant. 2012;12:2689-2699. [PMID: 22812390 DOI: 10.1111/j.1600-6143.2012.04161.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 2.5] [Reference Citation Analysis]
354 Zaouali MA, Bejaoui M, Calvo M, Folch-Puy E, Pantazi E, Pasut G, Rimola A, Ben Abdennebi H, Adam R, Roselló-Catafau J. Polyethylene glycol rinse solution: An effective way to prevent ischemia-reperfusion injury. World J Gastroenterol 2014; 20(43): 16203-16214 [PMID: 25473175 DOI: 10.3748/wjg.v20.i43.16203] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
355 Nii A, Utsunomiya T, Shimada M, Ikegami T, Ishibashi H, Imura S, Morine Y, Ikemoto T, Sasaki H, Kawashima A. A hydrolyzed whey peptide-based diet ameliorates hepatic ischemia–reperfusion injury in the rat nonalcoholic fatty liver. Surg Today 2014;44:2354-60. [DOI: 10.1007/s00595-014-0853-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
356 Xiong XF, Chen DD, Zhu HJ, Ge WH. Prognostic value of endogenous and exogenous metabolites in liver transplantation. Biomark Med 2020;14:1165-81. [PMID: 32969246 DOI: 10.2217/bmm-2020-0073] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
357 Kulkarni S, II DCC. Ethical tensions in solid organ transplantation: The price of success. World J Gastroenterol 2006; 12(20): 3259-3264 [PMID: 16718849 DOI: 10.3748/wjg.v12.i20.3259] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
358 Cameron AM, Ghobrial RM, Yersiz H, Farmer DG, Lipshutz GS, Gordon SA, Zimmerman M, Hong J, Collins TE, Gornbein J. Optimal utilization of donor grafts with extended criteria: a single-center experience in over 1000 liver transplants. Ann Surg. 2006;243:748-753; discussion 753-755. [PMID: 16772778 DOI: 10.1097/01.sla.0000219669.84192.b3] [Cited by in Crossref: 207] [Cited by in F6Publishing: 171] [Article Influence: 12.9] [Reference Citation Analysis]
359 Siskind EJ, Vandermeer F, Siskind TR, Bruno DA, Sultan S, Alvarez-Casas J, Stafford A, Lane B, Lamattina JC, Barth RN, Hanish SI. Postoperative Elevated Resistive Indices Do Not Predict Hepatic Artery Thrombosis in Extended Criteria Donor Livers. Int J Angiol 2017;26:238-40. [PMID: 29142490 DOI: 10.1055/s-0037-1598623] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
360 Barreto SG, Brooke-Smith ME, Neo EL, Dolan P, Leibbrandt R, Emery T, Carroll R, Wigg A, Chen JW. Exploring pre-surgery donor-specific antibodies in the context of organ shortage in liver transplant. Langenbecks Arch Surg 2019;404:865-74. [PMID: 31748871 DOI: 10.1007/s00423-019-01831-9] [Reference Citation Analysis]
361 Saidi SA, Meurisse N, Jochmans I, Heedfeld V, Wylin T, Parkkinen J, Pirenne J, Monbaliu D, El Feki A, van Pelt J. Hepatocellular uptake of cyclodextrin-complexed curcumin during liver preservation: A feasibility study. Biopharm Drug Dispos 2018;39:18-29. [PMID: 28972677 DOI: 10.1002/bdd.2108] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
362 Kondo Y, Ishitsuka Y, Kadowaki D, Fukumoto Y, Miyamoto Y, Irikura M, Hirata S, Sato K, Maruyama T, Hamasaki N, Irie T. Phosphoenolpyruvate, a glycolytic intermediate, as a cytoprotectant and antioxidant in ex-vivo cold-preserved mouse liver: a potential application for organ preservation. J Pharm Pharmacol 2013;65:390-401. [PMID: 23356848 DOI: 10.1111/j.2042-7158.2012.01602.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
363 Ekser B, Gridelli B, Tector AJ, Cooper DK. Pig liver xenotransplantation as a bridge to allotransplantation: which patients might benefit? Transplantation. 2009;88:1041-1049. [PMID: 19898198 DOI: 10.1097/tp.0b013e3181ba0555] [Cited by in Crossref: 44] [Cited by in F6Publishing: 15] [Article Influence: 3.7] [Reference Citation Analysis]
364 Goldaracena N, Cullen JM, Kim DS, Ekser B, Halazun KJ. Expanding the donor pool for liver transplantation with marginal donors. Int J Surg 2020;82S:30-5. [PMID: 32422385 DOI: 10.1016/j.ijsu.2020.05.024] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
365 Motiño O, Francés DE, Casanova N, Fuertes-Agudo M, Cucarella C, Flores JM, Vallejo-Cremades MT, Olmedilla L, Pérez Peña J, Bañares R, Boscá L, Casado M, Martín-Sanz P. Protective Role of Hepatocyte Cyclooxygenase-2 Expression Against Liver Ischemia-Reperfusion Injury in Mice. Hepatology 2019;70:650-65. [PMID: 30155948 DOI: 10.1002/hep.30241] [Cited by in Crossref: 21] [Cited by in F6Publishing: 26] [Article Influence: 7.0] [Reference Citation Analysis]
366 Fonseca-neto OCLD, Miranda LEC, Sabat BD, Amorim AG, Adeodato L, Melo PSVD, Lopes HC, Lacerda CM, Pereira LMMB. O doador marginal: experiência de um centro de transplante de fígado. ABCD, arq bras cir dig 2008;21:1-5. [DOI: 10.1590/s0102-67202008000100001] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
367 Banan B, Chung H, Xiao Z, Tarabishy Y, Jia J, Manning P, Upadhya GA, Mohanakumar T, Lin Y, Chapman WC. Normothermic extracorporeal liver perfusion for donation after cardiac death (DCD) livers. Surgery. 2015;158:1642-1650. [PMID: 26294088 DOI: 10.1016/j.surg.2015.07.016] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
368 Hitpass L, Amygdalos I, Sieben P, Raaff V, Lang S, Bruners P, Kuhl CK, Barabasch A. MRI-Based Quantitation of Hepatic Steatosis Does Not Predict Hypertrophy Rate after Portal Vein Embolization in Patients with Colorectal Liver Metastasis and Normal to Moderately Elevated Fat Fraction. J Clin Med 2021;10:2003. [PMID: 34067008 DOI: 10.3390/jcm10092003] [Reference Citation Analysis]
369 Teoh NC, Williams J, Hartley J, Yu J, McCuskey RS, Farrell GC. Short-term therapy with peroxisome proliferation-activator receptor-alpha agonist Wy-14,643 protects murine fatty liver against ischemia-reperfusion injury. Hepatology 2010;51:996-1006. [PMID: 20131406 DOI: 10.1002/hep.23420] [Cited by in Crossref: 4] [Cited by in F6Publishing: 14] [Article Influence: 0.3] [Reference Citation Analysis]
370 Andria B, Bracco A, Attanasio C, Castaldo S, Cerrito MG, Cozzolino S, Di Napoli D, Giovannoni R, Mancini A, Musumeci A, Mezza E, Nasti M, Scuderi V, Staibano S, Lavitrano M, Otterbein LE, Calise F. Biliverdin protects against liver ischemia reperfusion injury in swine. PLoS One 2013;8:e69972. [PMID: 23922878 DOI: 10.1371/journal.pone.0069972] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
371 Faber W, Seehofer D, Puhl G, Guckelberger O, Bertram C, Neuhaus P, Bahra M. Donor age does not influence 12-month outcome after orthotopic liver transplantation. Transplant Proc. 2011;43:3789-3795. [PMID: 22172848 DOI: 10.1016/j.transproceed.2011.10.048] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
372 Sayuk GS, Leet TL, Schnitzler MA, Hayashi PH. Nontransplantation of Livers from Deceased Donors Who Are Able to Donate Another Solid Organ: How Often and Why It Happens. Am J Transplant 2007;7:151-60. [DOI: 10.1111/j.1600-6143.2006.01600.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
373 Kubota T, Hata K, Sozu T, Ueda Y, Hirao H, Okamura Y, Tamaki I, Yoshikawa J, Kusakabe J, Tanaka H. Impact of Donor Age on Recipient Survival in Adult-to-Adult Living-donor Liver Transplantation. Ann Surg. 2018;267:1126-1133. [PMID: 28288061 DOI: 10.1097/sla.0000000000002194] [Cited by in Crossref: 29] [Cited by in F6Publishing: 9] [Article Influence: 9.7] [Reference Citation Analysis]
374 Xiao Z, Banan B, Xu M, Jia J, Manning PT, Hiebsch RR, Gunasekaran M, Upadhya GA, Frazier WA, Mohanakumar T, Lin Y, Chapman WC. Attenuation of Ischemia-Reperfusion Injury and Improvement of Survival in Recipients of Steatotic Rat Livers Using CD47 Monoclonal Antibody. Transplantation 2016;100:1480-9. [PMID: 27331362 DOI: 10.1097/TP.0000000000001186] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
375 Starzl TE, Murase N, Marcos A, Fung JJ. History of Liver and Multivisceral Transplantation. Transplantation of the Liver. Elsevier; 2005. pp. 3-22. [DOI: 10.1016/b978-0-7216-0118-2.50006-9] [Cited by in Crossref: 4] [Article Influence: 0.2] [Reference Citation Analysis]
376 Gracia-Sancho J, García-Calderó H, Hide D, Marrone G, Guixé-Muntet S, Peralta C, García-Pagán JC, Abraldes JG, Bosch J. Simvastatin maintains function and viability of steatotic rat livers procured for transplantation. J Hepatol. 2013;58:1140-1146. [PMID: 23428876 DOI: 10.1016/j.jhep.2013.02.005] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 4.8] [Reference Citation Analysis]
377 Kim DY, Moon J, Island ER, Tekin A, Ganz S, Levi D, Selvaggi G, Nishida S, Tzakis AG. Liver transplantation using elderly donors: a risk factor analysis. Clin Transplant. 2011;25:270-276. [PMID: 20184629 DOI: 10.1111/j.1399-0012.2010.01222.x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 34] [Article Influence: 3.6] [Reference Citation Analysis]
378 Pasut G, Panisello A, Folch-Puy E, Lopez A, Castro-Benítez C, Calvo M, Carbonell T, García-Gil A, Adam R, Roselló-Catafau J. Polyethylene glycols: An effective strategy for limiting liver ischemia reperfusion injury. World J Gastroenterol 2016; 22(28): 6501-6508 [PMID: 27605884 DOI: 10.3748/wjg.v22.i28.6501] [Cited by in CrossRef: 29] [Cited by in F6Publishing: 27] [Article Influence: 4.8] [Reference Citation Analysis]
379 Chu MJ, Hickey AJ, Phillips AR, Bartlett AS. The impact of hepatic steatosis on hepatic ischemia-reperfusion injury in experimental studies: a systematic review. Biomed Res Int. 2013;2013:192029. [PMID: 24062999 DOI: 10.1155/2013/192029] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 3.0] [Reference Citation Analysis]
380 Alvikas J, Deeb AP, Jorgensen DR, Minervini MI, Demetris AJ, Lemon K, Chen X, Labiner H, Malik S, Hughes C, Humar A, Tevar A. Moderately Macrosteatotic Livers Have Acceptable Long-Term Outcomes but Higher Risk of Immediate Mortality. Transplant Proc 2021;53:1682-9. [PMID: 33931249 DOI: 10.1016/j.transproceed.2021.03.024] [Reference Citation Analysis]
381 Noujaim HM, de Ville de Goyet J, Montero EF, Ribeiro CM, Capellozzi VL, Crescentini F, Casagrande M, Santos RG, Curvello L, de Miranda MP, Genzini T. Expanding Postmortem Donor Pool Using Steatotic Liver Grafts: A New Look. Transplantation 2009;87:919-25. [DOI: 10.1097/tp.0b013e31819b3f76] [Cited by in Crossref: 45] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
382 Miller-Matero LR, Eshelman A, Paulson D, Armstrong R, Brown KA, Moonka D, Abouljoud M. Beyond survival: how well do transplanted livers work? A preliminary comparison of standard-risk, high-risk, and living donor recipients. Clin Transplant 2014;28:691-8. [PMID: 24654861 DOI: 10.1111/ctr.12368] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
383 Friedman BH, Wolf JH, Wang L, Putt ME, Shaked A, Christie JD, Hancock WW, Olthoff KM. Serum cytokine profiles associated with early allograft dysfunction in patients undergoing liver transplantation. Liver Transpl 2012;18:166-76. [PMID: 22006860 DOI: 10.1002/lt.22451] [Cited by in Crossref: 70] [Cited by in F6Publishing: 68] [Article Influence: 7.0] [Reference Citation Analysis]
384 Peralta C, Jiménez-Castro MB, Gracia-Sancho J. Hepatic ischemia and reperfusion injury: effects on the liver sinusoidal milieu. J Hepatol. 2013;59:1094-1106. [PMID: 23811302 DOI: 10.1016/j.jhep.2013.06.017] [Cited by in Crossref: 277] [Cited by in F6Publishing: 273] [Article Influence: 30.8] [Reference Citation Analysis]
385 Ignacio Herrero J. III Reunión de consenso de la Sociedad Española de Trasplante Hepático (SETH). Hepatitis C, trasplante hepático de donante vivo, calidad de los injertos hepáticos y calidad de los programas de trasplante hepático. Gastroenterología y Hepatología 2011;34:641-59. [DOI: 10.1016/j.gastrohep.2011.05.011] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
386 Fusai G, Glantzounis GK, Hafez T, Yang W, Quaglia A, Sheth H, Kanoria S, Parkes H, Seifalian A, Davidson BR. N-Acetylcysteine ameliorates the late phase of liver ischaemia/reperfusion injury in the rabbit with hepatic steatosis. Clin Sci (Lond). 2005;109:465-473. [PMID: 15982189 DOI: 10.1042/cs20050081] [Cited by in Crossref: 35] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
387 Monbaliu DR, Debbaut C, Hillewaert WJ, Laleman WJ, Sainz-barriga M, Pirenne J, Segers P. Flow Competition between Hepatic Arterial and Portal Venous flow during Hypothermic Machine Perfusion Preservation of Porcine Livers. Int J Artif Organs 2012;35:119-31. [DOI: 10.5301/ijao.5000038] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
388 Fujita S, Mizuno S, Fujikawa T, Reed AI, Kim RD, Howard RJ, Hemming AW. Liver transplantation from donation after cardiac death: a single center experience. Transplantation. 2007;84:46-49. [PMID: 17627236 DOI: 10.1097/01.tp.0000267424.88023.7b] [Cited by in Crossref: 70] [Cited by in F6Publishing: 60] [Article Influence: 4.7] [Reference Citation Analysis]
389 Winter A, Féray C, Antoine C, Azoulay D, Daurès JP, Landais P. Matching Graft Quality to Recipient's Disease Severity Based on the Survival Benefit in Liver Transplantation. Sci Rep 2020;10:4111. [PMID: 32139780 DOI: 10.1038/s41598-020-60973-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
390 Farkas S, Hackl C, Schlitt HJ. Overview of the indications and contraindications for liver transplantation. Cold Spring Harb Perspect Med. 2014;4. [PMID: 24789874 DOI: 10.1101/cshperspect.a015602] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 4.3] [Reference Citation Analysis]
391 Taylor R, Pietroski R, Hagan M, Eisenbrey A, Fontana R. Seropositive Abdominal and Thoracic Donor Organs Are Largely Underutilized. Transplantation Proceedings 2010;42:4479-87. [DOI: 10.1016/j.transproceed.2010.10.011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
392 Mils K, Lladó L, Fabregat J, Baliellas C, Ramos E, Secanella L, Busquets J, Pelaez N. Resultados del trasplante hepático con donantes de más de 70 años. Cirugía Española 2015;93:516-21. [DOI: 10.1016/j.ciresp.2015.04.011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
393 Zhang M, Ueki S, Kimura S, Yoshida O, Castellaneta A, Ozaki KS, Demetris AJ, Ross M, Vodovotz Y, Thomson AW, B Stolz D, Geller DA, Murase N. Roles of dendritic cells in murine hepatic warm and liver transplantation-induced cold ischemia/reperfusion injury. Hepatology 2013;57:1585-96. [PMID: 23184590 DOI: 10.1002/hep.26129] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 3.6] [Reference Citation Analysis]
394 Yu L, Koepsell T, Manhart L, Ioannou G. Survival after orthotopic liver transplantation: the impact of antibody against hepatitis B core antigen in the donor. Liver Transpl. 2009;15:1343-1350. [PMID: 19790164 DOI: 10.1002/lt.21788] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 2.4] [Reference Citation Analysis]
395 Zaouali MA, Panisello-Roselló A, Lopez A, Castro Benítez C, Folch-Puy E, García-Gil A, Carbonell T, Adam R, Roselló-Catafau J. Relevance of proteolysis and proteasome activation in fatty liver graft preservation: An Institut Georges Lopez-1 vs University of Wisconsin appraisal. World J Gastroenterol 2017; 23(23): 4211-4221 [PMID: 28694661 DOI: 10.3748/wjg.v23.i23.4211] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
396 Zenitani M, Hosoda H, Kodama T, Saka R, Takama Y, Ueno T, Tazuke Y, Kangawa K, Oue T, Okuyama H. Postoperative decrease in plasma acyl ghrelin levels after pediatric living donor liver transplantation in association with hepatic damage due to ischemia and reperfusion injury. Pediatr Surg Int 2019;35:709-14. [DOI: 10.1007/s00383-019-04463-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
397 Duarte S, Hamada T, Kuriyama N, Busuttil RW, Coito AJ. TIMP-1 deficiency leads to lethal partial hepatic ischemia and reperfusion injury. Hepatology 2012;56:1074-85. [PMID: 22407827 DOI: 10.1002/hep.25710] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 3.2] [Reference Citation Analysis]
398 Shan Z, Alvarez-Sola G, Uriarte I, Arechederra M, Fernández-Barrena MG, Berasain C, Ju C, Avila MA. Fibroblast growth factors 19 and 21 in acute liver damage. Ann Transl Med 2018;6:257. [PMID: 30069459 DOI: 10.21037/atm.2018.05.26] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
399 Chung JH, Ryu JH, Yang KH, Choi BH, Park Y, Lee TB, Shim JR, Ko HJ, Cho SH. Efficacy and Safety of Weight Reduction of the Donor in Hepatic Steatosis for Living Donor Liver Transplantation. Ann Transplant 2020;25:e923211. [PMID: 32690857 DOI: 10.12659/AOT.923211] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
400 Briceño J, Ciria R, Pleguezuelo M, de la Mata M, Muntané J, Naranjo A, Sánchez-Hidalgo J, Marchal T, Rufián S, López-Cillero P. Impact of donor graft steatosis on overall outcome and viral recurrence after liver transplantation for hepatitis C virus cirrhosis. Liver Transpl 2009;15:37-48. [PMID: 19109846 DOI: 10.1002/lt.21566] [Cited by in Crossref: 69] [Cited by in F6Publishing: 56] [Article Influence: 5.3] [Reference Citation Analysis]
401 Kueht M, Bakhtiyar SS, Wu J, Liu H, Chan WH, Petrowsky H, Riaz IB, Cotton R, Galvan NT, O'Mahony C, Goss J, Rana A. The Transplant Index: A Novel Method to Predict Adult Liver Transplant Waitlist Outcomes. Transplantation 2019;103:1152-8. [PMID: 30300288 DOI: 10.1097/TP.0000000000002479] [Reference Citation Analysis]
402 Elias-Miró M, Jiménez-Castro MB, Mendes-Braz M, Casillas-Ramírez A, Peralta C. The Current Knowledge of the Role of PPAR in Hepatic Ischemia-Reperfusion Injury. PPAR Res 2012;2012:802384. [PMID: 22675337 DOI: 10.1155/2012/802384] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
403 Saidi RF, Kenari SKH. Liver Ischemia/Reperfusion Injury: an Overview. Journal of Investigative Surgery 2014;27:366-79. [DOI: 10.3109/08941939.2014.932473] [Cited by in Crossref: 63] [Cited by in F6Publishing: 66] [Article Influence: 7.9] [Reference Citation Analysis]
404 Petridis I, Gruttadauria S, Nadalin S, Viganò J, di Francesco F, Pietrosi G, Fili’ D, Montalbano M, D’Antoni A, Volpes R. Liver transplantation using donors older than 80 years: a single-center experience. Transplant Proc. 2008;40:1976-1978. [PMID: 18675105 DOI: 10.1016/j.transproceed.2008.05.063] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
405 Escartı́n A, Castro E, Dopazo C, Bueno J, Bilbao I, Margarit C. Analysis of Discarded Livers for Transplantation. Transplantation Proceedings 2005;37:3859-60. [DOI: 10.1016/j.transproceed.2005.08.050] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 1.3] [Reference Citation Analysis]
406 Saggi BH, Farmer DG, Yersiz H, Busuttil RW. Surgical advances in liver and bowel transplantation. Anesthesiol Clin North Am 2004;22:713-40. [PMID: 15541932 DOI: 10.1016/j.atc.2004.07.005] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
407 Pratschke S, Meimarakis G, Mayr S, Graeb C, Rentsch M, Zachoval R, Bruns CJ, Kleespies A, Jauch K, Loehe F, Angele MK. Arterial blood flow predicts graft survival in liver transplant patients: Organ Blood After Liver Transplantation. Liver Transpl 2011;17:436-45. [DOI: 10.1002/lt.22248] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
408 Eghtesad B, Kadry Z, Fung J. Technical considerations in liver transplantation: what a hepatologist needs to know (and every surgeon should practice). Liver Transpl. 2005;11:861-871. [PMID: 16035067 DOI: 10.1002/lt.20529] [Cited by in Crossref: 24] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
409 Fondevila C, Shen XD, Tsuchiyashi S, Yamashita K, Csizmadia E, Lassman C, Busuttil RW, Kupiec-Weglinski JW, Bach FH. Biliverdin therapy protects rat livers from ischemia and reperfusion injury. Hepatology 2004;40:1333-41. [PMID: 15565657 DOI: 10.1002/hep.20480] [Cited by in Crossref: 121] [Cited by in F6Publishing: 128] [Article Influence: 6.7] [Reference Citation Analysis]
410 Xiao ZY, Banan B, Jia J, Manning PT, Hiebsch RR, Gunasekaran M, Upadhya GA, Frazier WA, Mohanakumar T, Lin Y, Chapman WC. CD47 blockade reduces ischemia/reperfusion injury and improves survival in a rat liver transplantation model. Liver Transpl 2015;21:468-77. [PMID: 25482981 DOI: 10.1002/lt.24059] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.9] [Reference Citation Analysis]
411 Reeder SB, Cruite I, Hamilton G, Sirlin CB. Quantitative Assessment of Liver Fat with Magnetic Resonance Imaging and Spectroscopy. J Magn Reson Imaging. 2011;34:729-749. [PMID: 22025886 DOI: 10.1002/jmri.22775] [Cited by in Crossref: 52] [Cited by in F6Publishing: 266] [Article Influence: 4.7] [Reference Citation Analysis]
412 Oliver JB, Machineni P, Bongu A, Patel T, Nespral J, Kadric C, Goldstein MJ, Lerner H, Gee D, Hillbom R, Brown L, Washburn K, Koneru B. Liver biopsy in assessment of extended criteria donors: Oliver et al. Liver Transpl 2018;24:182-91. [DOI: 10.1002/lt.24947] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
413 Feng S, Goodrich NP, Bragg-Gresham JL, Dykstra DM, Punch JD, DebRoy MA, Greenstein SM, Merion RM. Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant. 2006;6:783-790. [PMID: 16539636 DOI: 10.1111/j.1600-6143.2006.01242.x] [Cited by in Crossref: 1279] [Cited by in F6Publishing: 1110] [Article Influence: 79.9] [Reference Citation Analysis]
414 Kim WH, Lee J, Ko JS, Min JJ, Gwak MS, Kim GS, Lee SK. Effect of remote ischemic postconditioning on patients undergoing living donor liver transplantation: REMOTE ISCHEMIC POSTCONDITIONING IN LT. Liver Transpl 2014;20:1383-92. [DOI: 10.1002/lt.23960] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
415 Matuszkiewicz-Rowińska J, Małyszko J, Wieliczko M. Renal support during liver transplantation: when to consider it? Transplant Proc 2013;45:3157-62. [PMID: 24182777 DOI: 10.1016/j.transproceed.2013.08.071] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
416 Killackey MT, Gondolesi GE, Liu LU, Paramesh AS, Thung SN, Suriawinata A, Nguyen E, Roayaie S, Schwartz ME, Emre S. Effect of ischemia-reperfusion on the incidence of acute cellular rejection and timing of histologic hepatitis C virus recurrence after liver transplantation. Transplant Proc. 2008;40:1504-1510. [PMID: 18589139 DOI: 10.1016/j.transproceed.2008.03.101] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
417 Nardone G, Compare D, Liguori E, Di Mauro V, Rocco A, Barone M, Napoli A, Lapi D, Iovene MR, Colantuoni A. Protective effects of Lactobacillus paracasei F19 in a rat model of oxidative and metabolic hepatic injury. American Journal of Physiology-Gastrointestinal and Liver Physiology 2010;299:G669-76. [DOI: 10.1152/ajpgi.00188.2010] [Cited by in Crossref: 63] [Cited by in F6Publishing: 58] [Article Influence: 5.3] [Reference Citation Analysis]
418 Oniscu GC, Adair A, Hidalgo E. Severe preprocurement blunt trauma to the liver: is there a need for back-table cutdown? Liver Transpl 2009;15:1647-8; author reply 1649. [PMID: 19877206 DOI: 10.1002/lt.21880] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
419 Dayangac M, Taner CB, Yaprak O, Demirbas T, Balci D, Duran C, Yuzer Y, Tokat Y. Utilization of elderly donors in living donor liver transplantation: when more is less? Liver Transpl. 2011;17:548-555. [PMID: 21506243 DOI: 10.1002/lt.22276] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 3.0] [Reference Citation Analysis]
420 Pantazi E, Zaouali MA, Bejaoui M, Serafin A, Folch-Puy E, Petegnief V, De Vera N, Ben Abdennebi H, Rimola A, Roselló-Catafau J. Silent information regulator 1 protects the liver against ischemia-reperfusion injury: implications in steatotic liver ischemic preconditioning. Transpl Int. 2014;27:493-503. [PMID: 24472096 DOI: 10.1111/tri.12276] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
421 Linecker M, Krones T, Berg T, Niemann CU, Steadman RH, Dutkowski P, Clavien PA, Busuttil RW, Truog RD, Petrowsky H. Potentially inappropriate liver transplantation in the era of the "sickest first" policy - A search for the upper limits. J Hepatol. 2018;68:798-813. [PMID: 29133246 DOI: 10.1016/j.jhep.2017.11.008] [Cited by in Crossref: 37] [Cited by in F6Publishing: 29] [Article Influence: 7.4] [Reference Citation Analysis]
422 Eggenhofer E, Groell A, Junger H, Kasi A, Kroemer A, Geissler EK, Schlitt HJ, Scherer MN. Steatotic Livers Are More Susceptible to Ischemia Reperfusion Damage after Transplantation and Show Increased γδ T Cell Infiltration. Int J Mol Sci 2021;22:2036. [PMID: 33670793 DOI: 10.3390/ijms22042036] [Reference Citation Analysis]
423 Mikulic D, Mrzljak A. Liver transplantation and aging. World J Transplant 2020; 10(9): 256-266 [PMID: 32995320 DOI: 10.5500/wjt.v10.i9.256] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
424 Karpeta E, Czerwiński J, Wasiak D, Małkowski P, Chmura A. Risk Factors in Cadaveric Donors of Livers Procured for Elective and Urgent Recipients. Transplantation Proceedings 2012;44:2250-2. [DOI: 10.1016/j.transproceed.2012.07.115] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
425 Godara R, Naidu CS, Rao PP, Sharma S, Banerjee JK, Saha A, Vijay K. Use of marginal grafts in deceased donor liver transplant: assessment of early outcomes. Indian J Gastroenterol 2014;33:136-40. [PMID: 23999685 DOI: 10.1007/s12664-013-0379-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
426 Nguyen JH, Bonatti H, Dickson RC, Hewitt WR, Grewal HP, Willingham DL, Harnois DM, Schmitt TM, Machicao VI, Ghabril MS. Long-term outcomes of donation after cardiac death liver allografts from a single center. Clin Transplant. 2009;23:168-173. [PMID: 19220366 DOI: 10.1111/j.1399-0012.2009.00968.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 3.0] [Reference Citation Analysis]
427 Hernández-Ruiz V, García-Lara JMA, Zamudio-Rodríguez A, García-Juárez I, Avila-Funes JA. Liver transplantation in Mexican older adults: A comparative single-center study. Rev Gastroenterol Mex (Engl Ed) 2019;84:455-60. [PMID: 31570173 DOI: 10.1016/j.rgmx.2018.09.003] [Reference Citation Analysis]
428 Selck FW, Grossman EB, Ratner LE, Renz JF. Utilization, outcomes, and retransplantation of liver allografts from donation after cardiac death: implications for further expansion of the deceased-donor pool. Ann Surg. 2008;248:599-607. [PMID: 18936573 DOI: 10.1097/sla.0b013e31818a080e] [Cited by in Crossref: 19] [Cited by in F6Publishing: 29] [Article Influence: 1.4] [Reference Citation Analysis]
429 Sagias FG, Mitry RR, Hughes RD, Lehec SC, Patel AG, Rela M, Mieli-Vergani G, Heaton ND, Dhawan A. N-acetylcysteine improves the viability of human hepatocytes isolated from severely steatotic donor liver tissue. Cell Transplant. 2010;19:1487-1492. [PMID: 20587150 DOI: 10.3727/096368910x514620] [Cited by in Crossref: 29] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
430 Dawwas MF, Gimson AE, Lewsey JD, Copley LP, van der Meulen JH. Survival after liver transplantation in the United Kingdom and Ireland compared with the United States. Gut. 2007;56:1606-1613. [PMID: 17356039 DOI: 10.1136/gut.2006.111369] [Cited by in Crossref: 54] [Cited by in F6Publishing: 48] [Article Influence: 3.6] [Reference Citation Analysis]
431 Nemes B, Gámán G, Polak WG, Gelley F, Hara T, Ono S, Baimakhanov Z, Piros L, Eguchi S. Extended criteria donors in liver transplantation Part I: reviewing the impact of determining factors. Expert Rev Gastroenterol Hepatol. 2016;10:827-839. [PMID: 26838962 DOI: 10.1586/17474124.2016.1149061] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 4.8] [Reference Citation Analysis]
432 Imamura H, Hidaka M, Soyama A, Kitasato A, Adachi T, Ono S, Natsuda K, Hara T, Kugiyama T, Baimakhanov Z. A Donor Age-Based and Graft Volume-Based Analysis for Living Donor Liver Transplantation in Elderly Recipients. Transplant Direct. 2017;3:e168. [PMID: 28706971 DOI: 10.1097/txd.0000000000000688] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
433 Johnson S, Alexopoulos S, Curry M, Hanto D. Primary Nonfunction (PNF) in the MELD Era: An SRTR Database Analysis. Am J Transplant 2007;7:1003-9. [DOI: 10.1111/j.1600-6143.2006.01702.x] [Cited by in Crossref: 58] [Cited by in F6Publishing: 47] [Article Influence: 3.9] [Reference Citation Analysis]
434 Wingfield LR, Ceresa C, Thorogood S, Fleuriot J, Knight S. Using Artificial Intelligence for Predicting Survival of Individual Grafts in Liver Transplantation: A Systematic Review. Liver Transpl. 2020;26:922-934. [PMID: 32274856 DOI: 10.1002/lt.25772] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
435 Kahn J, Pregartner G, Avian A, Kniepeiss D, Müller H, Schemmer P. The Graz Liver Allocation Strategy-Impact of Extended Criteria Grafts on Outcome Considering Immunological Aspects. Front Immunol 2020;11:1584. [PMID: 32849538 DOI: 10.3389/fimmu.2020.01584] [Reference Citation Analysis]
436 Baidya R, Gautheron J, Crawford DHG, Wang H, Bridle KR. Inhibition of MLKL Attenuates Necroptotic Cell Death in a Murine Cell Model of Ischaemia Injury. J Clin Med 2021;10:E212. [PMID: 33435617 DOI: 10.3390/jcm10020212] [Reference Citation Analysis]
437 Taniguchi M, Shimamura T, Todo S, Furukawa H. Small-for-size syndrome in living-donor liver transplantation using a left lobe graft. Surg Today. 2015;45:663-671. [PMID: 24894564 DOI: 10.1007/s00595-014-0945-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
438 Thorsen T, Aandahl EM, Bennet W, Olausson M, Ericzon BG, Nowak G, Duraj F, Isoniemi H, Rasmussen A, Karlsen TH. Transplantation With Livers From Deceased Donors Older Than 75 Years. Transplantation. 2015;99:2534-2542. [PMID: 25909464 DOI: 10.1097/tp.0000000000000728] [Cited by in Crossref: 20] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
439 Gruttadauria S, Cintorino D, Mandala’ L, Musumeci A, Volpes R, Vizzini G, Palazzo U, Spada M, Verzaro R, Gridelli B. Acceptance of Marginal Liver Donors Increases the Volume of Liver Transplant: Early Results of a Single-Center Experience. Transplantation Proceedings 2005;37:2567-8. [DOI: 10.1016/j.transproceed.2005.06.020] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.0] [Reference Citation Analysis]
440 Briceño J, Ciria R, Pleguezuelo M, Naranjo A, Sánchez-Hidalgo J, Ruiz-Rabelo J, López-Cillero P, Luque A, de la Mata M, Rufián S. Contribution of marginal donors to liver transplantation for hepatitis C virus infection. Transplant Proc 2007;39:2297-9. [PMID: 17889169 DOI: 10.1016/j.transproceed.2007.07.069] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 1.7] [Reference Citation Analysis]
441 Tanemura A, Mizuno S, Wada H, Yamada T, Nobori T, Isaji S. Donor age affects liver regeneration during early period in the graft liver and late period in the remnant liver after living donor liver transplantation. World J Surg. 2012;36:1102-1111. [PMID: 22374540 DOI: 10.1007/s00268-012-1496-1] [Cited by in Crossref: 42] [Cited by in F6Publishing: 40] [Article Influence: 4.2] [Reference Citation Analysis]
442 Hashimoto K, Miller C. The use of marginal grafts in liver transplantation. J Hepatobiliary Pancreat Surg 2008;15:92-101. [DOI: 10.1007/s00534-007-1300-z] [Cited by in Crossref: 40] [Cited by in F6Publishing: 29] [Article Influence: 2.9] [Reference Citation Analysis]
443 Pratschke S, Meimarakis G, Bruns CJ, Kaspar M, Prix N, Zachoval R, Guba M, Jauch KW, Loehe F, Angele MK. Temporary intraoperative porto-caval shunt: useless or beneficial in piggy back liver transplantation? Transpl Int. 2013;26:90-98. [PMID: 23237579 DOI: 10.1111/tri.12007] [Cited by in Crossref: 33] [Cited by in F6Publishing: 22] [Article Influence: 3.3] [Reference Citation Analysis]
444 Ghinolfi D, Marti J, De Simone P, Lai Q, Pezzati D, Coletti L, Tartaglia D, Catalano G, Tincani G, Carrai P, Campani D, Miccoli M, Biancofiore G, Filipponi F. Use of octogenarian donors for liver transplantation: a survival analysis. Am J Transplant. 2014;14:2062-2071. [PMID: 25307037 DOI: 10.1111/ajt.12843] [Cited by in Crossref: 72] [Cited by in F6Publishing: 57] [Article Influence: 9.0] [Reference Citation Analysis]
445 Xu C, Zhang X, Yu C, Lu G, Chen S, Xu L, Ding W, Shi Q, Li Y. Proteomic analysis of hepatic ischemia/reperfusion injury and ischemic preconditioning in mice revealed the protective role of ATP5β. Proteomics. 2009;9:409-419. [PMID: 19142948 DOI: 10.1002/pmic.200800393] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.4] [Reference Citation Analysis]